Document:

EXHIBIT 10.14

 

TRADEMARK LICENSE AGREEMENT

 

THIS TRADEMARK LICENSE AGREEMENT (this
"Agreement") is made and entered into as of December 9, 2011 (the "Effective Date") by and between
S. C. Johnson & Son, Inc., a Wisconsin corporation with a business address of 1525 Howe Street, Racine, WI 53403
(hereinafter “LICENSOR”), and CTI Industries Corporation, an Illinois corporation having a principal place of business
at 22160 N. Pepper Road, Lake Barrington, IL 60010 (hereinafter “LICENSEE”).

 

WHEREAS, LICENSOR is the owner of the Trademarks;
and

 

WHEREAS, LICENSEE wishes to market and
sell certain products in the Distribution Channels in the Territory under the Trademarks; and

 

WHEREAS, LICENSOR is willing to license
and allow LICENSEE to use the Trademarks on the terms and conditions set forth in this Agreement.

 

Now, therefore, in consideration of the
foregoing, the covenants hereinafter set forth, and other good and valuable consideration, the receipt and adequacy of which are
hereby acknowledged, the parties agree as follows:

 

1.          Certain
Definitions. The following terms used in this Agreement shall have the following meanings (whether used in the singular
or the plural):

 

“Advertising
Materials” means all advertising, packaging, promotional, sales and other materials including, without limitation, LICENSEE’s
website content that makes any use of or reference to the Licensed Products
or Trademarks (or any one or more of them).

 

“Affiliate”
shall mean any entity controlling, controlled by or under common control with any such named person, where control means the power
to direct the management and policies of a party, directly or indirectly, whether through the ownership of voting securities, by
contract or otherwise.

 

"Change in
Control" means the occurrence of any of the following events: (a) the acquisition (whether by merger, consolidation, amalgamation,
share exchange, business combination, issuance of securities, acquisition of securities, recapitalization, tender offer, exchange
offer or other transaction) by any individual, entity or group of fifty percent (50%) or more of the combined voting power of the
then-outstanding voting securities of LICENSEE; or (b) any sale, lease, exchange, transfer, license, acquisition or disposition
of all or substantially all of the assets of LICENSEE, in each case whether in a single or series of transactions.

 

“Distribution
Channels” means the kitchen appliance store section only of Mass Market Retail Stores, Grocery Stores, Drug Stores, Warehouse
Club Stores, Hardware Stores, Home Improvement Stores, Specialty Stores, and Value Stores (collectively “Stores”),
and such other channels (including certain online and direct marketing channels) targeted toward consumers as LICENSOR may from
time to time authorize in writing. ''''''''' '''''''''''''''''''''''''' ''''''' '''''''''''''''''''
''''''''''''''' '''''''''' '''''''' '''''''''''''''''' ''''''''' ''''''''''' '''''''''' '''''''''''''''''''' ''''''''''''''''''''''
'''''''''''''''''' '''''''''''''''''''' ''''''' '''''''''''''''''''''''''''''''''''' '''''''''''''' ''''''''''''''''''''''' ''''''''''
'''''''''''''''' '''''''''''''''''' '''''''''''''''' ''''' ''''''''''' ''''''''''''' ''''''''''''' '''''''''''''''' ''''''''''''''
'''''''''''''''''''' '''''''' '''''''''''''''''''' '''''''''''' '''''''''''''''' '''''''''''''''''''' ''''''''''''''' ''''' ''''''''''''''''''
''''' ''''''' ''''''''''''''''

 

    	1

    	 

    

 

“Earned Royalty”
means a royalty in the amount of ''''''''' '''''''''''''''' ''''''''''' on ''''''''
'''''''' ''''''''''''''''' ''''''''''''''' '''''''''''''''' ''''''''''''''''''''''''''''''''
of Sales of Licensed Products by LICENSEE and its sublicensees, to be increased to ''''''
'''''''''''''''' '''''''''' on all Sales of Licensed Products by LICENSEE and its sublicensees in excess of
that threshold amount for the remainder of the Term; provided, however, that the Earned Royalty shall be '''''''''''''''
'''''''''''''''''' ''''''''''''''' of Sales of Licensed Products by LICENSEE and its sublicensees for all
Licensed Products sold in violation of the terms of this Agreement, including (but not limited to) the provisions
of Section 6 below.

 

"Force Majeure
Event" means any event, circumstance or condition which is beyond a party's control and which has a material effect on
such party's ability to perform its obligations under this Agreement, including, without limitation, war, terrorism, riot,
labor strike or lock-out, fire, flood, wind, storm, Act of God, and changes in governmental regulation.

 

“Guaranteed
Minimum Royalty” means the following minimum royalties to be paid by LICENSEE to LICENSOR under this Agreement:

 

(a)    During
the Term (as defined in Section 13(a) below), the Guaranteed Minimum Royalty is ''''''''''''
''''''''''''''''''' '''''''' ''''''''' '''''''''''''''''''' ''''''''''''''' ''''''''''''''''''''''''''''
which shall be payable as follows:

 

(i)    for
Contract Period 1 (as defined in Section 13(a) below), '''''''''''''''''''''
payable in four (4) equal quarterly installments in the amount of '''''''''''''''''
each within thirty (30) days following the calendar quarter-end, in this case on or before April 30, 2012; July 30, 2012; October
30, 2012; and January 30, 2013 '''''''''' ''' '''''''''''''' ''''' ''''''''''''''''''
''''''''''''''' ''''''''''' ''''''''''''''''''''' '''''''''''''''''''''''''' ''''' ''''''''''''''''' ''''''' ''''''' '''''''''''''''''''''''''''''''''''
'''''''''''''''''''' '''' '''''''' ''''''''''''''''' '''''' ''''''''''''''''''' ''''' ''''''''''''''' ''''''''''''''' '''' '''''''''''''''
'''''''''''''''''''''''''''''''''

 

(ii)    for
Contract Period 2 (as defined in Section 13(a) below), ''''''''''''''''''''
payable in four (4) equal quarterly installments in the amount of '''''''''''''''''
each within thirty (30) days following the calendar quarter-end, in this case on or before April 30, 2013; July 30, 2013; October
30, 2013; and January 30, 2014; and

 

(iii)    for
Contract Period 3 (as defined in Section 13(a) below), '''''''''''''''''''''''
payable in four (4) equal quarterly installments in the amount of '''''''''''''''''''
each within thirty (30) days following the calendar quarter-end, in this case on or before April 30, 2014; July 30, 2014;
October 30, 2014; and January 30, 2015.        

 

“Initial Sale
Date” means July 1, 2012.

 

“Licensed
Products” means products within the Licensed Product Category that bear the Trademark, including the packaging
bearing the Trademark, and are specifically approved by LICENSOR in writing as a Licensed Product hereunder.

 

    	2

    	 

    

 

“Licensed
Product Category” means the following food storage consumer product category: A countertop, powered food storage vacuum
sealing kitchen appliance(s) (“Appliances”) and associated non-zippered plastic food storage vacuum bags (“Bags”)
for use solely in connection with that appliance or similar third party appliances. The bags would either be sold with one open
end to be sealed with the appliance or in plastic film rolls to be sealed at both ends, as bags of various sizes, by the appliance.
This category would not include hand held manual or powered food storage vacuum sealing devices and bags associated with such devices.

 

“Marketing
Commitment” means a LICENSOR approved marketing plan detailing the level of commitment LICENSEE will make to support
the Sales of Licensed Products as detailed in Exhibit J hereto.

 

“Safety, Health,
Environment (S/H/E)" means industry standards and other standards promulgated or regulated by the US Occupational Safety
and Health Administration, the US Environmental Protection Agency, state or local agencies and, if applicable, other federal, state
or local agencies charged with protecting safety, health, and environment which in each case relate to employee safety, employee
health and the natural or human environment.

 

“Sales”
means gross invoice price of Licensed Products less actual bona fide returns for defective Licensed Products
or credits given to customers for defective Licensed Products in lieu of returns, up to a maximum of five percent (5%) of
the gross invoice price, which shall be supported by a credit memoranda actually issued to a customer. No other deduction or recoupment
shall be allowed of any kind, including, without limitation and by way of example: (a) cash discounts; (b) early payment discounts;
(c) year-end rebates; (d) costs incurred, including in manufacturing, selling, distributing, advertising (including cooperative
and promotional allowances, fixturing, merchandising guides, displays or the like), and shipping and handling; (e) uncollectible
accounts; (f) commissions; or (g) any other amounts. Furthermore, such deductions or recoupment shall not be netted against
the sales price to arrive at the gross invoice price or any reduced gross invoice price. A sale shall be deemed to have occurred
when the Licensed Products are shipped, transferred or invoiced by LICENSEE, whichever occurs first, or an Approved Sublicensee
as applicable. Whenever Licensed Products are sold or transferred in whole or in part in transactions in which some or all
of the consideration is non-monetary, or where the transferee is an Affiliate of LICENSEE, the invoice price shall be deemed
to be  LICENSEE's list price to non-affiliated buyers for Licensed Products; provided, however, that if such an Affiliate
is an authorized Approved Sublicensee under Section 16 below, the Sale shall be deemed to have occurred
at the time the Licensed Products are shipped, transferred or invoiced by such Affiliate, whichever occurs first.

 

“Term”
means the period this Agreement is in effect, as determined pursuant to Section 13(a) below.

 

"Territory”
means the following countries: the ''''''''''''''''' ''''''''''''''''
'''''''''''''''''' '''''''''''''''''' ''''''''''''''' ''''''''''' and any other countries mutually agreed to in writing
by the parties.

 

“Trademark"
means each and every trademark identified on Exhibit A hereto, including all common law rights therein and, with respect
to each registered trademark on Exhibit A hereto, all renewals thereof.

 

    	3

    	 

    

 

2.          Grant
of License. 

 

(a)          Scope
of License. Subject to the terms and conditions contained in this Agreement, LICENSOR hereby grants to LICENSEE a personal,
non-assignable, non-transferable, sole, limited license to use the Trademark in connection with the manufacture, distribution
(subject to Sections 2(c) and 4 below), marketing, and sale of Licensed Products in the Licensed Product Category
within the Distribution Channels in the Territory. LICENSEE shall not individually brand or co-brand any product
in the Licensed Product Category or directly or indirectly manufacture, have manufactured, license, market, or sell
any similar or competitive products in the License Product Category, with a brand or house mark (private label or otherwise)
other than the Trademark within the Distribution Channels in the Territory. All other rights in and to the
Trademarks are reserved by LICENSOR.

 

(i)          Notwithstanding
any other provision of this Agreement:

 

(A)         During
the Term, the LICENSOR shall not appoint other licensees to use the Trademark in the Licensed Product Category
for the marketing and sale of products in the Licensed Product Category within the Distribution Channels in the Territory.
However, LICENSOR and its Affiliates retain the right to manufacture, have manufactured, purchase from suppliers, market,
distribute and sell any and all types of products, new or existing, in the Distribution Channels, including without limitation
products in the Licensed Product Category, under the Trademark or another brand(s) and, further, retains the right
to appoint other licensees to manufacture product with the Trademark for marketing and sale in the Licensed Product Category
within the Distribution Channels in the Territory during the Term so long as the goods are not shipped to
customers prior to the end of the Term.

 

(B)         In
the event LICENSOR acquires, by any means, brands, products or rights to products that are similar to or competitive with any of
the Licensed Products, then LICENSOR has the right to use such brands and to manufacture, have manufactured, purchase from
suppliers, market, distribute, license and sell any and all such products, together with any new products and/or product line extensions,
under those brands or other brands including the Trademark, through any and all distribution channels including the Distribution
Channels.

 

(C)         ''''''''''''''''''''''''''
'''''''''''' ''''''''''' ''''''' '''''''''' ''''' '''''''''''''''''''' ''''' '''''' '''''''''''''''''' '''''''''''''''''''''''''''''''
'''''''''''' ''''''''''''' '''''''''''''''''''''''''''''''' ''''''''''''''''''' ''''''''''' ''''' ''''''' ''''''''''''' ''''''''''''
''''''''''''''' '''''' ''''''''''''''''''''''' ''''''' ''''''' ''''''''''''''''''''''''''' '''''''''''''''' ''''''''' '''''''
'''''''''''''''''''''''''''''''' '''''''''''''''' '''''''''''' '''''''''''''''''' '''''''''''''''''' '''''''''''''''''''''''
''''' ''''''' '''''''''''''' '''''''''''''' '''''''''''''' ''''' ''''''' ''''''''''''''''' ''''''''''''''' ''''''''' '''''''''''''''''''
'''''''''''''' ''''''''''' ''''''''''''''''''' ''''''''''' ''''' ''''''' '''''''''''''''''' '''''''''''''''' ''''''''''''''''''''
'''''''' '''''''''' ''''''''''''' '''''''''''''''' ''''''' ''''''' '''''''''''''''''''''''' ''''' ''''''' '''''''''''' ''''''''''''''''
''''' ''''''''''' ''''''''''' ''''''''''' ''''''''''''''''' '''''''''''''''''' '''''''''''''''''''' ''''''' ''''''''''''''''''''
'''''''''''' ''''''''''''' '''''' ''''''''''''''''' ''''''''''''''''''' ''''' ''''''''''''''''' ''''' '''''''''''''' ''''''''''
'''''' '''''''''''' '''''''''''''' '''''''''''' '''''''''''''''''''''' '''''''''''''''''''' ''''''''''''''' '''''''' ''''''''''''''''''''''''
''''''''''''''''''''''' ''''''''''' '''''''' ''''''''''''''''''''' '''''''''''''' '''''''''' ''''''' '''''' '''''''' '''''''''''''''''''
''''''' ''''''''''''''''''''''' ''''''''' ''''''''' '''' ''''''''''' ''''' '''''''''''''''''''' ''''''''''' ''''''''''' '''''''''''''
'''' ''''''''''' ''''''''''''''''' '''''''''''''''' ''''''''''''''' ''''''''' ''''''''' '''''''' '''''''''''''''''' ''''''''''''''''''''
'''''''''''' '''''''''' ''''''''''''' ''''' ''''''' ''''''''''''' '''''''''''' '''''''''''''''''''''' '''''''' '''''''''
'''''''''''''''''''''''''''' ''''''''''''''' '''''''' ''''''''' '''''''''''''''''''''''''''''''' '''''''''''''''''' '''''''''''''''
''''''' '''''''''''''''' ''''''''''''' ''''' ''''''' ''''''''''''''' ''''''''''''' '''''''''''''''' '''''
''''''' '''''''''''''''''''' '''''''''''''' ''''''''' '''''''''''''''''''' ''''''''''''''' '''''''''''' ''''''''''''''''''''
''''''''' ''''' ''''''' '''''''''''''''''''' '''''''''''''''''' ''''''''''''''''''' '''''''''' '''''''''' ''''''''''''
'''''''' ''''''' ''''''''''''''''''''''''' ''''' '''''' '''''''''''' ''''''''''''''''' '''''' ''''''''''''' '''''''''''' ''''''''''
''''''' ''''''' '''''''' '''' ''''''''''''''''''''''' '''''''''' '''''''' ''''''''''''' '''''''''''''''' '''''''''
'''''''''''''''''''' '''''''' '''''''''' '''' '''''''''''' ''''' ''''''''''''''''''' '''''''''''' '''''''''''' '''''''''''''' ''''
'''''''''''' '''''''''''''''' '''''''''''''''' '''''''''''''''' '''''''' '''''''''' '''''' '''''''''''''''''' ''''''''''''''''''''''
''''''''''' '''''''''''' ''''''''''''''' ''''' ''''''' ''''''''''''' ''''''''''''' ''''''''''''

 

    	4

    	 

    

 

(b)          Reservation
of Rights. Except for the specific rights granted to LICENSEE under this Agreement, all rights in and to the Trademark
are explicitly reserved and retained by LICENSOR. LICENSEE shall not have the right to sublicense any of the rights granted to
it under this Agreement, except to Approved Sublicensees in accordance with Section 16 below.  

 

(c)          Manufacture
of Licensed Products outside the Territory. Notwithstanding the territorial limitations contained in Section
2(a) above, LICENSEE may, at its option, manufacture Licensed Products outside the Territory, but any such Licensed
Products so manufactured must be sold only through the Distribution Channels in the Territory in accordance with
this Agreement. Furthermore, if LICENSEE elects to manufacture Licensed Products outside of the Territory
pursuant to this Section, LICENSEE shall be responsible for compliance with all applicable laws (and associated fees, duties and
other expenses) relating to the export of such products from the country of manufacture and the import of such products into the
Territory.

 

(d)          Performance
Requirements. Subject to the rights of early termination set forth in Section 13 below, the license grant under Section
2(a) of this Agreement shall remain a sole grant of rights (subject to LICENSOR’s reserved rights described in
Sections 2(a) and (b) above) for the Term of this Agreement, so long as the following performance requirements
are met:

 

	Contract Period	 	
        Sales of Licensed Products

        in the Distribution Channels

        in the Territory

	1	 	''''''''''''''''''''''''
	 	 	 
	2	 	'''''''''''''''''''''''
	 	 	 
	3	 	''''''''''''''''''''''''''''

 

If LICENSEE fails to
achieve a performance requirement specified in the above table, then the license rights granted under this Agreement shall
become non-exclusive effective at the end of the period with respect to which the performance requirement was not achieved (as
set forth in the above table) and shall thereafter remain non-exclusive for the remainder of the Term.

 

3.          Methods
of Sale. LICENSEE shall sell, ship and distribute the Licensed Products only through the Distribution Channels
for sale in the Territory. LICENSEE may not, without the prior written consent of LICENSOR, sell Licensed Products
on approval, consignment, sale or return basis or to inventory liquidators or in job lots, closeouts or remainder sales. LICENSEE
shall not use or sell Licensed Products as premiums or promotional items and shall not discriminate against the Licensed
Products by granting commission or discounts to salespersons, dealers and/or distributors in favor of LICENSEE's other products;
provided, however, that such restriction is not intended to prevent LICENSEE’s use of Licensed Products for incidental
marketing and promotional purposes (i.e., in reasonable quantities consistent with normal industry practices).

 

    	5

    	 

    

 

4.          Agreements
with Manufacturers.  Subject to LICENSOR’s written approval, LICENSEE may arrange with others to manufacture Licensed
Products or components thereof for the exclusive sale, use, and distribution by LICENSEE, provided that LICENSEE first obtains
any such third party’s agreement to comply with all of the terms of this Agreement by executing the document attached
hereto as Exhibit B. Any breach of this provision by a manufacturer appointed by LICENSEE which is not cured within
thirty (30) days following written notification by LICENSOR to LICENSEE of such breach shall be considered a breach of this Agreement
by LICENSEE.

 

5.          Royalties.

 

(a)          Amount.
LICENSEE, in addition to complying with all of the other terms and conditions of this Agreement, shall pay to LICENSOR,
in consideration of the rights granted by LICENSOR to LICENSEE under Section 2 of this Agreement, royalties in an
amount equal to the greater of (i) the Earned Royalty or (ii) the Guaranteed Minimum Royalty. Royalties
shall be paid on a calendar-quarter basis, as more particularly described in Section 5(b) below.

 

(b)          Payment
of Royalties. Royalties owed hereunder shall be calculated and paid on a calendar-quarter basis with the amount owed for a
particular calendar quarter being the greater of the Earned Royalty for such calendar quarter or the Guaranteed Minimum
Royalty installment payable for such calendar quarter, as required under Section 5(a) above, within thirty (30) days
following the last day of each calendar quarter. In the case of delay in payment by LICENSEE to LICENSOR of any installment of
royalties owed hereunder, interest at an annual rate of three percent (3%) over the prevailing prime interest rate as fixed and
published by Citibank in New York City, New York, shall be assessed as from the first day following the date such installment was
due and payable to LICENSOR without special notice. No portion of the Guaranteed Minimum Royalty or Earned Royalty
shall be refundable to LICENSEE upon expiration or termination of this Agreement. 

 

(c)          Deductions.
There shall be no deduction from royalties for uncollectible amounts, taxes based on LICENSEE's income or sales, fees, assessments,
or other expenses of any kind which may be incurred or paid by LICENSEE in connection with performance of this Agreement.
No other costs incurred by LICENSEE in the manufacturing, selling, advertising, and distribution of the Licensed Products
shall be deducted for purposes of determining royalties owed hereunder. Notwithstanding the foregoing, the royalty payable by LICENSEE
to LICENSOR may be reduced by any applicable foreign withholding taxes imposed on the LICENSEE’s royalty payments; provided
that LICENSEE promptly provides LICENSOR with documentation (i.e. tax forms) showing proof of payment of the applicable withholding
tax. The documentation to be provided by LICENSEE must be sufficient to enable LICENSOR to receive a credit against its United
States tax liability related to its royalty income under this Agreement.

 

(d)          Reports.
LICENSEE shall provide LICENSOR with a report of transactions relating to Licensed Products on which royalties have accrued,
in the form attached hereto as Exhibit C (each a “Royalty Report”), for each calendar quarter during
the Term. LICENSEE shall forward each Royalty Report to the LICENSOR contact person at the applicable address listed
on Exhibit D attached hereto. LICENSEE shall furnish to LICENSOR a full and complete report, duly certified by an officer
of LICENSEE to be true and accurate, showing the number of each type of such Licensed Product sold in the Territory
during the calendar quarter in question, and the total Sales for each such Licensed Product, together with any other
information requested by LICENSOR. In the event there have not been any transactions relating to such Licensed Products
during a particular calendar quarter, LICENSEE shall provide LICENSOR with a report confirming such
inactivity. Royalty Reports shall be due thirty (30) days after the end of each calendar quarter. 

 

    	6

    	 

    

 

(e)          Retention
of Records; Audits. During the Term and for a period of three (3) years thereafter, LICENSEE shall keep full and accurate
books of account and copies of all documents and other materials relating to this Agreement at LICENSEE's principal office.
Upon reasonable advance written notice, LICENSOR, its agents or representatives, shall have the right to audit such books, documents,
and other materials as may be necessary to verify LICENSEE’s compliance with the terms of this Agreement (including,
without limitation, verification of the accuracy of royalties paid), shall have access thereto during ordinary business hours,
and shall be allowed to make copies of such books, documents, and other materials. Unless LICENSEE fails to properly account to
and pay royalties owed to LICENSOR, or LICENSOR has reasonable cause to believe such, there shall be no more than two (2) audits
conducted during any Contract Period. At LICENSOR's request, LICENSEE shall make one (1) of its employees available to assist
in the examination of LICENSEE's records. If any audit of LICENSEE's books and records reveals that LICENSEE has failed to properly
account to and pay royalties owed to LICENSOR, and the amount of royalties due for any quarterly or annual period exceeds the amount
actually paid by five percent (5%) or more, LICENSEE shall, in addition to paying LICENSOR such past due royalties, reimburse LICENSOR
for its expenses incurred in conducting the audit together with interest on the overdue royalty amount at an annual rate of three
percent (3%) over the prevailing prime interest rate as fixed and published by Citibank in New York City, New York and in effect
as of the date on which such overdue royalty amount should have been paid to LICENSOR.

 

(f)          Currency.
All royalties payable hereunder shall be paid in United States Dollars. For purposes of converting Sales in denominations
other than United States Dollars to United States Dollars, LICENSEE shall use the applicable conversion rate set forth in the Wall
Street Journal on the date the royalty is due or the date such payment is made, whichever occurs first.

 

6.          Product
Quality.

 

(a)          Quality
Standards.

 

(i)          LICENSEE
acknowledges that the quality of Licensed Products must be  the highest in order
to preserve and maintain LICENSOR's reputation and the goodwill inherent in the Trademarks, and
agrees that failure to adhere to LICENSOR's quality standards as set forth on Exhibit E hereto ("Standards")
will impair the value and goodwill associated with the Trademarks. LICENSEE therefore agrees that prior to the sale of a
Licensed Product, it shall follow the material submission procedures as provided on Exhibit F hereto and utilize
the submission form as set forth on Exhibit G hereto. LICENSEE shall submit three (3) samples of the Licensed Product,
together with a copy of the Licensed Product specifications (“Specifications”), to LICENSOR for written
approval, as provided on Exhibit F hereto. LICENSOR shall use reasonable efforts to provide written approval or disapproval
of any Licensed Products within fifteen (15) business days after receipt thereof. LICENSOR’s failure to approve or
disapprove within such period shall be deemed disapproval, unless LICENSOR subsequently notifies LICENSEE of its written approval.
LICENSOR shall have the right, in its sole discretion, to approve or disapprove any Licensed Products.  Once
LICENSOR's final review and approval has been obtained, LICENSEE agrees that it shall not deviate from the approved samples and
Specifications without LICENSOR’s written approval. If LICENSOR determines that the Licensed Product does not
conform to the approved samples and Specifications, LICENSEE shall immediately stop the manufacture, distribution and sale
of the nonconforming Licensed Product. Failure to follow the procedures as provided on Exhibit F hereto shall
deem all materials unapproved and subject to immediate recall. LICENSOR reserves the right to change the material submission procedures
and form. LICENSEE further agrees to comply with LICENSOR's Quality Requirements as they relate
to Acceptable Quality Levels (AQLs) for product quality. 

 

    	7

    	 

    

 

(ii)         ''''''''''''
'''' ''''''''''''''''''''''''''''''''' ''''''''''''''''''''''''''' ''''''''''''''''''''''''''''''' ''''' '''''' '''''''''''''
'''''''''''''' ''''''''''''''''''' '''' '''''''' '''''''''''''''''' ''''''''''''''''''''''''''' '''''''''''' ''''''''''''''''''
'''''''''''''''''''''''''''' '''''''''' '''''' ''''''''''''''''''''''''''' ''''''''''''''''' ''''''''''''''' ''''''''''''''''''''
''''''''''''' '''' ''''''''''''''''' ''''''''''''''''''''''''''''' '''''''''''''''''''''''''''''' ''''''''''''''''''' ''''''' ''''''''''''''''''''''''''''
''''''''''' ''''''''''''''''''''''''''''''' ''''''''''''''' ''''''''''''''''''''' ''''''''''''''''''' '''''''' '''''''''''''''
''''''''''''''' '''''''''''''''''''''''''' ''''''''''''''''' '''''''''''''''''''''''' If LICENSOR determines that LICENSEE’s
manufacturing facilities do not comply with such standards, LICENSOR shall provide notice to LICENSEE of such determination and
shall specify in such notice the manner in which LICENSEE’S manufacturing facilities do not comply with such standards. If
LICENSEE’S manufacturing facilities do not comply within thirty (30) days of receipt of notice, either party may terminate
this Agreement upon written notice to the other party within twenty five (25) days after expiration of the relevant cure
period as stated herein; provided, however, that if compliance is capable of being achieved, albeit not within the thirty (30)
day cure period, and LICENSEE is diligently working to comply, then the period described in this Section shall be extended to forty-five
(45) days from receipt of notice. Any such termination of this Agreement shall relieve LICENSEE of any further obligation
to make payment of Guaranteed Minimum Royalties that accrue and are payable after the date of termination of this Agreement.

 

(iii)        '''''''''''''''''''''''''
''''''''''''''' ''''''' ''''' ''''''''''''''' '''''''' ''''''''''''''' ''''''''''''''' ''''''''' ''''''''''''''''' '''''''''
''''' '''''''''''''''''''''''''''''' ''''''''''''''''''' ''''''' ''''''''''''''''''''' ''''''''''''''''' ''''''''' ''''''''''''''
'''' '''''''''''''''' '''''''''' ''''''''''''''''''''''''''''''''''' '''''''''''''''''''' '''''''''''''''''''''''' '''''''''''''''''
''''''''' '''''''''''''''''''' '''''' '''''''''''''''''''' '''''' '''''''''''''''' '''''' ''''''''''''''''''''''''''' ''''''''''''
'''''''''' '''' ''''''''' ''''''''''' ''''''''''''''' ''''' ''''''''''''''''''''''''''''''''' ''''''''''' '''''''''''''''''''''
'''''''''''''''''''''''''' '''' '''''''''' '''''''''''''''''''''''''' ''''''' '''''''''''' ''''''''''''''''''''''''' ''''''''''''
''''''''''''''''' '''''''''''''''''''''' ''''' '''''''''''''''''''''''''''''' ''''''''''''''''''' '''''''''''''''''''''''''' ''''''''''''''''
'''' '''''''''''''''''''''''''''''''' ''''''''''''''''' ''''''''''''' '''''''''''''''''''''''''' '''''''''''''''''''''''''' ''''''''''''''''
'''''''''''''''''''''''''''''' ''''''' '''''''''''''''''''''''' '''''''''''''''' '''''''''''''' '''''''''''''''''''''''''' ''''''''
'''''''''''''''' '''''''''''''''''''''''''''''''''' ''''''''''''' '''''''' ''''''''''''''''''' ''''''''''''''''' ''''''''''''''
''''''''' ''''''''''''''''''''''''' ''''''''' '''''''''' ''''''''''''''''''' '''''''''' '''''''''''''''' '''''''''''''''' ''''
''''''''''''''''''''''''''' '''''''''' '''''''' '''''''''''''''''''''''' ''''''' ''''''''''' '''''' '''''''''''''''''' ''''' ''''''''''''''''.
In the event none of the Licensed Products meet all of LICENSOR’s testing standards, this Agreement may be
terminated by either party upon written notice without further obligation on the part of LICENSEE to make payment of Guaranteed
Minimum Royalties that first accrue and are payable after the date of termination of this Agreement.

 

(b)          Provision
of Samples. LICENSEE shall furnish free of charge to LICENSOR twenty-four (24) samples of each Licensed Product finished
good, including packaging, from the first production run. LICENSOR may request an additional twelve (12) samples of each Licensed
Product finished good, including packaging, per year, and if such a request is made, LICENSEE shall furnish the additional
samples.

 

    	8

    	 

    

 

(c)          Right
to Inspect.

 

(i)          Independent
Product Audit. LICENSOR reserves the right to institute an independent inspection program for Licensed Products produced
at LICENSEE's facility. This inspection may either be conducted by LICENSOR or an independent third-party service selected by LICENSOR.

 

(ii)         System
Audits. Upon reasonable notice from LICENSOR, LICENSEE shall permit representatives of LICENSOR to enter LICENSEE's premises
and plant(s) during normal business hours for the purpose of inspecting LICENSEE's plant(s), equipment, records, operation and
supplies that relate to the manufacture, distribution and sale of the Licensed Products. LICENSEE further agrees to cooperate
with LICENSOR and strive to achieve a 4.0 on the Supplier Quality Audit as outlined on Exhibit E hereto.

 

(d)          Changes
in Standards. LICENSOR shall have the right from time to time to change, withdraw or supplement the Standards set forth
in Exhibit E attached hereto or its approval of Licensed
Products previously authorized for use and sale by LICENSEE. LICENSOR’s right to change, withdraw or supplement a prior
approval of a Licensed Product shall include, but not be limited to, the right to require, from time to time and at any
time, that a Licensed Product be reformulated or removed from the definition of Licensed Products due to the presence
of a chemical on LICENSOR’s proprietary brown list of raw materials. LICENSEE shall have a reasonable period of time, not
to exceed six (6) months without prior written approval, to reformulate the Licensed Product and/or to cease sale of such
Licensed Product and, thereafter, to dispose of its existing inventory of Licensed Products, at LICENSEE’s
cost, by a means approved of by LICENSOR. If the changes to the Standards or approved samples result from a decision not
made in LICENSOR's sole discretion, then LICENSEE shall implement all changes immediately at its own expense. If LICENSEE reformulates
a Licensed Product under this Section 6(d), then LICENSEE shall requalify the Licensed Product pursuant
to the terms of this Agreement. In the event LICENSEE determines reformulation is not commercially reasonable or it is determined
that the reformulated Licensed Products do not meet all of LICENSOR’S revised Standards, this Agreement
may be terminated by either party upon written notice to be given to the other party within sixty (60) days of such a determination,
without further obligation on the part of LICENSEE to make payment of Guaranteed Minimum Royalties that first accrue and
are payable after the date of termination of this Agreement.

 

(e)          Licensed
Product Warranty. LICENSEE represents and warrants that the Licensed Products will be manufactured in compliance with
the Specifications, be of good quality, free from defects in design, material, and workmanship and will be merchantable and suitable
for their intended purpose; that no injurious, deleterious, or toxic substances will be used in or on the Licensed Products;
that the Licensed Products will not cause harm when used in a foreseeable manner; and that LICENSEE will, at its own expense,
comply with all laws, regulations and industry standards, including those relating to the operation of LICENSEE's plants, the manufacture,
sale and distribution of the Licensed Products, including the labeling thereof and including safety standards and testing
of the Licensed Products. LICENSEE further represents and warrants that the Licensed Products will be suitable for
food contact applications as defined by the U.S. FDA and the equivalent standards in Territories outside of the United States.

 

    	9

    	 

    

 

(f)          Product
Safety.

 

(i)          Each
party shall promptly notify the other when and if either has reason to believe that any Licensed Product poses or may pose
a health or safety risk, or is not or may not comply with any laws or regulations. In addition, LICENSEE shall promptly notify
LICENSOR of any claims, lawsuits, reports or allegations of adverse effects related to the Licensed Products which could
give rise to a reporting obligation under federal and/or state laws. LICENSEE shall also give LICENSOR prompt notice of all product
liability claims involving any Licensed Product. LICENSEE shall have, subject to prior consultation with LICENSOR, the right
to take any action it reasonably determines to be appropriate with respect to a Licensed Product, including but not limited
to, withdrawing or recalling the affected Licensed Product, provided that, unless LICENSEE has been advised by independent
outside counsel reasonably acceptable to LICENSOR that such action is required by applicable law, LICENSOR shall have the right
to approve in advance any proposed Licensed Product recall, retrieval or withdrawal, public announcement or other response
if LICENSOR believes in good faith that such action would have a material adverse effect on LICENSOR’s business. In the event
LICENSEE is deciding whether to withdraw or recall a Licensed Product, LICENSEE (A) shall promptly provide LICENSOR
with details of the events that gave or are giving rise to the consideration of a possible recall, (B) shall keep LICENSOR
promptly advised of decisions concerning the recall, and (C) shall show LICENSOR any draft announcements concerning the affected
Licensed Product before making such announcement, and give LICENSOR the opportunity to collaborate with LICENSEE on them.
LICENSEE shall provide LICENSOR with this information by live telephone discussions with the Quality Control Representatives listed
on Exhibit D hereto, and not merely by leaving voice mail messages if LICENSOR’s contact persons are unavailable.
LICENSEE shall reimburse LICENSOR for its costs for any recall.

 

(ii)         Notwithstanding
Section 6(f)(i) above, if LICENSEE elects not to recall, retrieve or withdraw the Licensed Product or to notify any
governmental or regulatory authority, and LICENSOR continues to have a reasonable and good faith belief that (A) the misbranding,
adulteration, or other health or safety risk associated with the Licensed Product is reasonably likely to give rise to significant
personal injury or property damage, (B) the Licensed Product contains a material defect or otherwise constitutes a
defective product which is reasonably likely to give rise to significant personal injury or property damage, (C) the manufacturing,
promoting, using, selling or distributing of the Licensed Product constitutes a material violation of applicable laws or
regulations, or (D) the continuance of the sale or distribution of such Licensed Product would have a material adverse
effect on LICENSOR’s business, LICENSOR may demand by notice that LICENSEE shall conduct a recall, retrieval or withdrawal
of the Licensed Product and/or notify the appropriate governmental or regulatory authorities. In the event of such a remedial
demand by LICENSOR, LICENSEE shall promptly take appropriate steps to effect a recall, retrieval or withdrawal of such Licensed
Product in the manner contemplated by the remedial demand. The costs and expenses of any recall, retrieval or withdrawal shall
be paid by LICENSEE.

 

(g)          Consumer
Complaints. All consumer complaints shall be handled by, and directed to, LICENSEE; provided, however, that LICENSEE shall
immediately forward to LICENSOR all consumer complaints regarding the Licensed Products which may affect the reputation,
products, marks or business of LICENSOR. LICENSOR and LICENSEE shall confer on how to handle or respond to such complaints; provided,
however, that LICENSOR shall have the right to respond to all such material consumer complaints or inquiries concerning the Licensed
Products or Advertising Materials. LICENSEE agrees to provide a telephone number for consumer inquiries and complaints.
LICENSEE agrees to handle all complaints in a timely and professional manner and use its best efforts to satisfy customers. LICENSEE
agrees to log all consumer complaints, along with contact information, into a database for tracking purposes. LICENSEE shall submit
a summarized report of complaints received thirty (30) days after the end of each calendar quarter along with the Royalty Report.
Additionally, from time to time, LICENSOR may request a report of complaints received and LICENSEE must provide the report within
ten (10) working days of the request.

 

    	10

    	 

    

 

(h)          Manufacturing
Standards. LICENSEE shall ensure that the production and/or manufacture of Licensed Products and/or Advertising Materials,
whether by LICENSEE or by third party manufacturers or suppliers selected by LICENSEE with LICENSOR’s approval (individually,
a "Manufacturer" and collectively, the “Manufacturers”), complies with the following requirements
set forth in this Section. LICENSEE shall ensure such compliance by Manufacturers before they contribute to production of
Licensed Products and at all times during such production.

 

(i)          LICENSEE
and the Manufacturers shall not use child labor (not including child actors or models) in the manufacturing, packaging,
marketing, advertising, or distribution of the Licensed Products.

 

(ii)         LICENSEE
and the Manufacturers shall only employ persons whose presence is voluntary. LICENSEE and the Manufacturers shall
not use any forced or involuntary labor.

 

(iii)        LICENSEE
and the Manufacturers shall treat each employee with dignity and respect, and shall not use corporal punishment, threats
of violence, abuse, or other forms of physical, sexual, psychological, or verbal harassment.

 

(iv)        LICENSEE
and the Manufacturers shall not unlawfully discriminate in any hiring or employment practices.

 

(v)         LICENSEE
and the Manufacturers shall comply with all applicable wage and hour laws, rules, regulations, and industry standards. Where
local industry standards are higher than applicable legal requirements, LICENSEE and the Manufacturers shall meet the higher
local standards. 

 

(vi)        LICENSEE
and the Manufacturers shall comply with all applicable workplace laws, rules, regulations, and industry standards, ensuring,
at a minimum, fire safety, adequate lighting and ventilation, and reasonable access to potable water and sanitary facilities.

 

(vii)       LICENSEE
and the Manufacturers shall respect the rights of employees to associate, organize, and bargain collectively in a lawful
and peaceful manner, without penalty or interference.

 

(viii)      LICENSEE
and the Manufacturers shall comply with all applicable environmental laws, rules, regulations, and industry standards.

 

    	11

    	 

    

 

LICENSOR and its designated
agents (including third parties) may engage in monitoring activities to confirm compliance with this Section. LICENSEE shall promptly
reimburse LICENSOR for the actual costs of inspections performed pursuant to this Section if any of LICENSEE’s manufacturing
facilities or those of any Manufacturer are determined by LICENSOR or its agents to have failed to comply with the terms
of this Section; provided, however, that LICENSOR shall notify LICENSEE in writing of the nature of any such failure and LICENSEE
or Manufacturer shall have thirty (30) days to cure any such failure. If LICENSEE becomes aware that any Manufacturer
has used or is using Trademarks for any unauthorized purpose, LICENSEE shall immediately notify LICENSOR and, if so instructed
by LICENSOR, shall cause such Manufacturer to cease such use immediately. LICENSEE shall supply
LICENSOR with the addresses of its proprietary manufacturing facilities for the Licensed Products, as well as those
of its permitted sub-manufacturers, if any, before any such facilities contribute to production of Licensed Products.

 

7.          Advertising
Materials.

 

(a)          Approval
of Advertising Materials. LICENSEE shall electronically submit one (1) draft copy or otherwise send three (3) draft
copies of all Advertising Materials to LICENSOR for its review and written approval before printing, producing or using
such Advertising Materials. LICENSEE shall follow the material submission procedures as provided
on Exhibit F hereto and utilize the submission form as set forth on Exhibit G hereto. Failure to follow the
procedures as provided on Exhibit F hereto shall deem all materials unapproved and such materials shall not be distributed.
LICENSOR reserves the right to change the material submission procedures and form.

 

(b)          Time
for Approval. LICENSOR shall use reasonable efforts to provide written approval or disapproval for any Advertising Materials
within ten (10) business days after receipt thereof. LICENSOR’s failure to approve or disapprove within such period shall
be deemed disapproval, unless LICENSOR subsequently notifies LICENSEE of its written approval.  LICENSOR
shall have the right, in its sole discretion, to approve or disapprove any Advertising Materials.

 

8.          Sale
of Licensed Products.

 

(a)          Initial
Approval and Sale. If by the Initial Sale Date LICENSEE has not received and accepted one or more purchase orders from
a national or regional customer account for Licensed Products providing for shipment of such Licensed Products in
each country of the Territory no later than August 31, 2012, LICENSOR shall have the right to terminate the license granted
herein for such Territory immediately by giving notice of termination to LICENSEE in relation to that Territory or
Territories; provided, however, that if the subject Territory is the United States, then LICENSOR shall have the
right to terminate this Agreement in its entirety.

 

(b)          Exploitation
of Rights. LICENSEE agrees that during the Term, it shall diligently and continuously distribute, ship and sell all
of the Licensed Products in the Territory and that it shall use its best efforts to manufacture the Licensed Products
in sufficient quantities to meet the reasonably anticipated demand in the Territory. LICENSOR shall have the right to terminate
this Agreement if LICENSEE, for any reason, after the commencement of sale, shipment and distribution of Licensed Products,
fails for a period in excess of sixty (60) days to continue to sell, ship and distribute such Licensed Products in the Territory.
LICENSEE shall use commercially reasonable efforts to promote the Licensed Products throughout the Territory consistent
with its normal business practices.

 

    	12

    	 

    

 

(c)          Sale
to LICENSOR. LICENSEE agrees to sell to LICENSOR, on request, reasonable quantities of each Licensed Product
at LICENSEE's cost thereof. No royalties shall be due on sales to LICENSOR. LICENSOR shall have the right to resell any such Licensed
Product in LICENSOR’s company stores (and such sales shall not be considered a violation of
this Agreement). 

 

9.          Protection
of the Trademarks.

 

(a)          Registrations.
LICENSOR shall have the right, in its sole discretion, to file trademark, trade dress, copyright, logos, graphical designs, or
other applications in the Territory or elsewhere, relating to the use or proposed use by LICENSEE of the Trademark
and to record this Agreement. Such filings shall be made in the name of LICENSOR or in the name of any third party selected
by LICENSOR. LICENSEE shall assist LICENSOR at LICENSOR’s expense, to the extent necessary in LICENSOR’s opinion, in
procuring, protecting and defending any of LICENSOR’s rights in the Trademark, in the filing and prosecution of any
trademark application, copyright application or other applications for the Trademark, the recording or canceling of this
Agreement, and the publication of any notices or the doing of any other act or acts with respect to the Trademark,
including the prevention of the use thereof by an unauthorized person, firm or corporation, that in the judgment of LICENSOR may
be necessary or desirable. For these purposes, LICENSEE shall supply to LICENSOR, free of cost to LICENSOR, such samples, containers,
labels and similar materials as may reasonably be required in connection with any such actions. LICENSEE shall not file any applications
for the Trademark or for trademarks LICENSOR deems confusingly similar to the Trademark, without the express written
consent of LICENSOR.

 

(b)          Prohibited
Uses of the Trademarks. LICENSEE shall not use the Trademark in combination with any other trademark,
word, symbol, letter or design, or as part of its company name or in connection with any product other than the Licensed Products.
Further, LICENSEE agrees not to adopt any trademark, trade dress, trade name, design, logo or symbol which is similar to or likely
to be confused with any of the Trademarks or Licensed Product packaging during the Term of this Agreement
or thereafter. LICENSEE shall not, directly or indirectly, in any way dispute or impugn the validity of the Trademarks,
or LICENSOR's sole ownership and right to use and control the use of the Trademarks during the Term of this Agreement
and thereafter. LICENSEE shall not do or permit to be done any action or thing which shall in any way impair LICENSOR's rights
in and to the Trademarks. LICENSEE acknowledges that its use of the Trademarks shall not create in it any right,
title or interest therein and agrees that all use thereof shall be for the benefit of LICENSOR.

 

(c)          Copyright
Protection. LICENSEE recognizes the importance to LICENSOR of preserving copyright protection and registrations therefore on
all copyrightable works embodied in any graphics, logos, or other artistic elements embodied in or in connection with the Trademark
and on all copyrightable works relating to the Trademark, including without limitation Advertising Materials, trade dress
and packaging graphics, and new works and derivative works related thereto ("Copyrights"), and the importance
of securing copyright protection for the Copyrights for copyright law purposes, and for all materials which include representations
of the Trademarks which appear on or in connection with Licensed Products or on or in connection with the Advertising
Materials. Therefore, LICENSEE shall place a copyright notice(s) in the name(s) specified by LICENSOR on all Licensed Products
and Advertising Materials. The copyright notice shall be placed near the trademark notice described in Section 9(f),
and shall be in such a format as LICENSOR shall reasonably specify. LICENSEE agrees that it shall not affix to the Licensed
Products or the Advertising Materials a copyright notice in its name or the name of any other person, firm, or corporation,
except as requested or approved by LICENSOR. LICENSEE agrees that proper copyright notices must be affixed to all Licensed Products
and Advertising Materials bearing copyrightable matter in a manner that is sufficient in size, legibility, form, location,
and permanency to comply with both the United States copyright laws and also the copyright notice requirement of the Universal
Copyright Convention.

 

    	13

    	 

    

 

(d)          Intentionally
Left Blank.

 

(e)          Assignment
by LICENSEE. All uses of the Trademark by LICENSEE shall inure to the benefit of LICENSOR, which shall own all Trademarks,
trademark rights, copyrights and other intellectual property rights created by such uses. To the extent LICENSEE acquires any rights
to any of the Copyrights or Trademarks, LICENSEE hereby assigns and transfers to LICENSOR all such rights, together
with the goodwill of the business in connection therewith, and agrees to execute any documentation relating to such assignment.
LICENSEE hereby assigns and transfers to LICENSOR its entire worldwide right, title, and interest in and to all "new works,”
"derivative works" and/or “joint works” heretofore or hereafter created using all or any portion of the Trademarks
including, but not limited to, the Copyrights and renewal copyrights thereon. If parties who are not employees of LICENSEE
living in the United States make or have made any contribution to the creation of a work, so that such parties might be deemed
to be "authors" as that term is used in present or future United States copyright statutes, LICENSEE agrees to obtain
from such parties a full assignment of rights so that the foregoing assignment by LICENSEE shall vest in LICENSOR full rights in
the work, free of any claims, interests, or rights of other parties. LICENSEE shall not permit any of its employees to obtain or
reserve any rights as "authors" of such works and agrees to furnish LICENSOR with full information concerning the creation
of new works and/or derivative works and with copies of assignments of rights obtained from other parties, and to execute, without
charge, any documents requested by LICENSOR for such purposes. In each circumstance, in addition to all other steps as may be necessary,
LICENSEE shall have its contractors sign the form attached hereto as Exhibit I.

 

(f)          Trademark
Notice. LICENSEE shall affix or cause its authorized manufacturing sources to affix to the packaging for the Licensed Products,
the Licensed Products and Advertising Materials the following notice (and such other notices as may be requested
from time to time by LICENSOR in relation to LICENSOR's trademark, copyright, patent or other protection), as applicable; (i) “[Trademark®]
is a registered trademark of S.C. Johnson & Son, Inc. used under license”; or (ii) “[Trademark] is a trademark
of S.C. Johnson & Son, Inc. used under license.”

 

10.         Infringements.
If LICENSEE learns that a third party may be infringing the Trademark, LICENSEE shall promptly provide LICENSOR with
written notice providing any details it knows about the use. LICENSOR shall decide what, if any, action to take, but shall have
no obligation to take any action. LICENSEE shall cooperate with LICENSOR, at LICENSOR’s expense,
in any action it takes to stop infringements. LICENSOR may settle any dispute relating to the use of the Trademarks without
notice or compensation to LICENSEE, and shall retain the proceeds of any settlement or proceeding.

 

    	14

    	 

    

 

11.         Indemnification.

 

(a)          LICENSEE's
Indemnification Obligations. LICENSEE agrees to indemnify and hold LICENSOR harmless, from any and all claims, liabilities,
judgments, penalties, losses, costs, damages, and expenses resulting therefrom, including reasonable attorneys' fees, arising out
of any of the following: ''''''''''''' ''''''''''''''''''''''''''' '''''''''''''''''''''''''''
'''''''''''''''''''''''' '''''''''' ''''''''' ''''''''' ''''' ''''''''' '''''''''''''' ''''''''''''''''' ''''''''''''''''''''
''''''''''''''''''' ''''''''''''''''''''''''' ''''''''' ''''''''''''' '''''''''''''''''''''''''' '''''''''''''''''' '''''''''''''''''''''
''''''''''''' '''''''''''''''' ''''' '''''''''''''''''''' ''''''''''''''' '''''''''''''''''' '''''''''''''''''' ''''''''''''''
''''''''''''''' ''''''''''''' '''''' ''''''''' '''''''''' '''''''''''' ''''''''''''''''''''''''''''''''''''' ''''''' '''''' '''''''
''''''''''''''''''''''''' ''''''''''' '''''''''''' ''''' ''''''''''''''''''''''' ''''''''''''''''''' ''''''''''' ''''''''''' ''''''''
'''''''''''''''''''' '''''''' ''''''''''''''''''' '''''''''''''''''''' '''''' '''''''''''''''''''''''''''' ''''' ''''' ''''''''''''''''''''''''
'''''''''''''' ''''''''''''' ''''''''''''''''''' '''''''''''''''''''' '''''''''''' ''''' ''' ''''''''''''' ''''' ''''''''' '''''
'''''''''''''''''''''' ''''' '''''''''' '''''''''''''''' ''''''''''''''''''''''' '''''' '''''''''''''''''''''''''''' '''' '''''''''''''''''''''''''''
''''''''''''''' '''''''''''''''''' ''''''''''''''' ''''''''''''' '''''''''''' '''''''''''' ''''''' ''''''''' ''''' '''''''
''''''''''''''''' ''''' '''''''''''''''''''''''' ''''' ''' '''''''''''''''''' '''''''''''''' ''''''' '''''''''''' ''''''''''''''''''''''''
'''''''''''''''''''''' '''''' '''''''''''''''''''''''''''' ''''' '''''''''''' '''''''''''''''''''''''''''' ''''''''''' '''''''
'''''''''''' ''''' ''''''''' ''''''''''''''''''' '''''' ''''''''''''''''''' ''''''''''''''''''''''' '''''''''''' '''''''''''''''''''''''''''''''
'''''''''''''''''''''' ''''' '''''''''''''''''''''''''''' The right to be indemnified and held harmless under this Section
shall not be exclusive, but shall be in addition to any and all other rights and remedies to which LICENSOR may be entitled under
this Agreement or otherwise.

 

(b)          Claims
Procedures. With respect to the foregoing indemnification obligations: (i) LICENSEE agrees promptly to notify and keep
LICENSOR fully advised with respect to such claims and the progress of any suits in which the LICENSOR is not participating; (ii) LICENSOR
shall have the right to assume, at its sole expense, the defense of a claim or suit made or filed against the LICENSEE; (iii) intentionally
omitted; (iv) LICENSEE shall not settle such claim or suit without the prior written approval of the LICENSOR, which shall
not be unreasonably withheld.

 

12.         Insurance.

 

(a)          Insurance
Required. LICENSEE agrees to obtain, at its own cost, from an insurance company with a rating by A.M. Best of A- or better,
and class VIII or better, the insurance described in Sections 12(b) and 12(c) below, and to maintain that insurance
during the Term and until the later to occur of the following: (i) Licensed Products are no longer offered for
sale to end users, or (ii) two (2) years have elapsed after the termination or expiration date. Before the sale of any Licensed
Products, LICENSEE shall furnish LICENSOR with a certificate of insurance evidencing the insurance coverages required herein
and confirming that LICENSOR has been named as an additional insured on such policies, and that such insurance shall not be cancelled,
non-renewed, or materially modified without thirty (30) days prior written notice to LICENSOR. The policy certificates shall be
delivered to the applicable individual listed on Exhibit D hereto.

 

(b)          Commercial
General Liability Insurance. LICENSEE's Commercial General Liability Insurance shall specifically provide coverage for products
liability, completed operations, advertising liability and contractual liability covering any and all losses, claims, demands,
causes of action and settlements, including attorneys’ fees, with a minimum limit of '''''''''''
'''''''''''''''''' '''''''''''''''''' ''''''''''''''''''''''''''''' per occurrence
and '''''''''' ''''''''''''''''' ''''''''''''''''' '''''''''''''''''''''''''''''''
in the aggregate, with a self-insured retention not in excess of ''''''''''' '''''''''''''''''''''
'''''''''''''''''''''' ''''''''''''''''' ''''''''''''''''''''''''''', unless a higher retention is approved in writing in
advance by LICENSOR.

 

(c)          Umbrella
Liability Insurance Coverage. LICENSEE may provide (during the period described in Section 12(a) above) an umbrella
liability policy as evidence of additional limits to meet the general liability insurance requirement in Section 12(b).

 

    	15

    	 

    

 

(d)          Primary
Insurance. LICENSEE’s policies shall be primary and non-contributory as to any other valid and collectible insurance
policy available to LICENSOR.

 

13.         Term
and Termination.

 

(a)          Term.
Subject to early termination as provided in this Section, the Term of this Agreement shall begin on the Effective
Date and run as follows:

 

	Term	 	 
	Contract Period 1:	 	Effective Date – December 31, 2012
	Contract Period 2:	 	January 1, 2013 – December 31, 2013
	Contract Period 3:	 	January 1, 2014 – December 31, 2014

 

(b)          LICENSOR’s
Immediate Right of Termination. LICENSOR shall have the right to terminate this Agreement upon notice to LICENSEE if:

 

(i)          LICENSEE
fails to make timely payment of royalties or fails to make timely submission of royalty statements as provided in Section 5
above and such failure is not cured within five (5) days after notice of nonpayment/nonsubmission is given by LICENSOR to LICENSEE,
but if LICENSEE fails to make royalty payments or submit royalty statements on a timely basis more than two (2) times in any twelve
(12) month period, then LICENSOR may, at its option, terminate this Agreement immediately upon notice to LICENSEE upon the
next such failure to timely pay royalties or timely submit royalty statements; 

 

(ii)         LICENSEE
assigns or transfers this Agreement without LICENSOR’s consent as required herein, or LICENSEE acts in any way which
effects or constitutes a sublicense to any party other than an Affiliate Approved Sublicensee in accordance with
Section 16 below;

 

(iii)        LICENSEE
or any Approved Sublicensee becomes insolvent, or a petition in bankruptcy or for reorganization is filed by or against
it, or any insolvency proceedings are instituted by or against it, or LICENSEE or any Approved Sublicensee makes
an assignment for the benefit of its creditors, is placed in the hands of a receiver, or liquidates its business, it being understood
that if LICENSOR terminates this Agreement as authorized herein, LICENSEE and any Approved Sublicensee, its and their
receivers, trustees, assignees, or other representatives shall have no right to sell, exploit, or in any way deal with the Licensed
Products, Trademark or the Advertising Materials, except with the express written consent of LICENSOR;

 

(iv)        in
LICENSOR’s sole discretion, LICENSOR determines that any acts or omissions of LICENSEE (or any Approved Sublicensee)
and/or any acts or omissions of a Manufacturer, without regard to any cure period under this Agreement applicable
to such Manufacturer acts or omissions) in connection with its use of the Trademark (which shall include, without
limitation, the sale of defective products or products which create health or safety hazards) has damaged or otherwise impaired
the Trademark;

 

(v)         it
appears to LICENSOR that the use of the Trademark in association with the Licensed Products is likely to, or may
reasonably be taken to, violate the intellectual property rights of another person;

 

    	16

    	 

    

 

(vi)        LICENSEE
or any Approved Sublicensee makes, sells, offers for sale, distributes or uses any Licensed Product or item of Advertising
Material without having the prior written approval of the LICENSOR or agent, as required by Sections 6 and 7 above,
it being understood that LICENSEE’s payment of a higher Earned Royalty for any Licensed Products sold without
LICENSOR’s prior approval shall not preclude LICENSOR’s ability to enforce any other provision of this Agreement,
including its immediate right of termination under this Section 13; or

 

(vii)       LICENSEE or
any Affiliate sublicensee undergoes a Change in Control; the LICENSEE (or any Affiliate sublicensee),
John H. Schwan or Stephen Merrick or any member of their immediate families or any Affiliate of any such person,
or any officer of LICENSEE or any Approved Sublicensee sells or otherwise transfers any of its or his/her equity
interests to a competitor of LICENSOR; or any competitor of LICENSOR has the right to elect or appoint a person to the Board of
Directors of LICENSEE, or any officer, director or other designee of a competitor is elected or appointed to the Board of Directors
of LICENSEE.

 

(c)          LICENSEE’s
Immediate Right of Termination. LICENSEE shall have the right to terminate this Agreement upon notice to LICENSOR if LICENSOR
becomes insolvent, or a petition in bankruptcy or for reorganization is filed by or against it, or any insolvency proceedings are
instituted by or against it, or LICENSOR makes an assignment for the benefit of its creditors, is placed in the hands of a receiver,
or liquidates its business.

 

(d)          Other
Grounds to Terminate for Breach. If LICENSEE or any Approved Sublicensee breaches any of the terms of
this Agreement other than those specified in Section 13(b) above and fails to cure the breach within thirty (30)
days after receiving written notice thereof, this Agreement shall terminate at the end of the thirty (30) day period; provided,
however, that if the breach is capable of being cured, albeit not within thirty (30) days, and LICENSEE or the applicable Approved
Sublicensee is diligently working to cure the breach, then the cure period described in this Section shall be extended to forty-five
(45) days.

 

(e)          Effect
of Termination. If this Agreement is terminated by LICENSOR pursuant to Section 13(b)(iv) above, then LICENSEE
shall pay to LICENSOR, within thirty (30) days after the termination date (i) all royalties owed hereunder for calendar quarters
prior to the calendar quarter in which the termination occurs, (ii) with respect to the calendar quarter in which termination occurs,
the greater of the Guaranteed Minimum Royalty installment owed for such calendar quarter or all Earned Royalties
owed with respect to such calendar quarter which are unpaid at the termination date, and (iii) the Guaranteed Minimum Royalty
installments owed for the next three (3) calendar quarters following the calendar quarter in which the termination occurs. If this
Agreement is terminated by LICENSOR pursuant to Section 13(d) or 13(b) other than pursuant to subpart (b)(iv)
above, then LICENSEE shall pay to LICENSOR, within thirty (30) days after the termination date, an amount calculated as follows:
(A) the aggregate amount of the Guaranteed Minimum Royalty for the entire Term including, if renewed, any Renewal
Term plus (B) the excess of Earned Royalties over the Guaranteed Minimum Royalty for all calendar quarters
prior to the date of termination, minus (C) the aggregate amount of royalties paid by LICENSEE to LICENSOR under this Agreement
through the termination date. If this Agreement is terminated by LICENSEE pursuant to Section 13(c) above for any
reason, then LICENSEE shall pay to LICENSOR within thirty (30) days after the termination date (1) all royalties owed hereunder
for calendar quarters prior to the calendar quarter in which the termination occurs, and (2) with respect to the calendar quarter
in which termination occurs, the greater of the Guaranteed Minimum Royalty installment owed for such calendar quarter or
all Earned Royalties owed with respect to such calendar quarter which are unpaid at the termination date. Termination or
expiration of this Agreement shall be without prejudice to any rights or claims which LICENSOR may otherwise have against LICENSEE
or any Approved Sublicensee.

 

    	17

    	 

    

 

(f)          Discontinuance
of Use of the Trademark. Subject to the provisions of Section 13(g) below, upon the expiration or termination
of this Agreement, LICENSEE and all Approved Sublicensees shall immediately discontinue manufacturing, selling,
advertising, distributing, and using the Licensed Products and Advertising Materials and terminate all agreements
with manufacturers, distributors, and others which relate to the manufacture, sale, distribution, and use of the Licensed Products.

 

(g)          Disposition
of Inventory Upon Expiration. Notwithstanding the provisions of Section 13(f) above, if this Agreement expires
in accordance with its terms or is terminated by LICENSEE in accordance with Section 13(c) above, LICENSEE shall have the
right to sell the Licensed Products on hand as of the date of such expiration or termination, for a period of ninety (90)
days immediately following such expiration or termination, subject to payment of royalties to LICENSOR on any such sales and compliance
with all the terms of this Agreement. The sell-off right granted to LICENSEE is expressly conditioned on LICENSEE's providing
LICENSOR, within ten (10) days of the expiration or termination of this Agreement, with an accurate inventory of all Licensed
Products on hand at the time of expiration or termination. Following the sell-off period, at LICENSOR’s option and at
LICENSEE’s expense, LICENSEE shall either: (i) deliver to LICENSOR all packages, labels, signage, stationery and other
materials bearing the Trademark which are in LICENSEE’s possession or control, or (ii) remove from all items
in LICENSEE’s possession or control, and destroy, all packages, labels, signage, stationery and other materials bearing the
Trademark.

 

14.         Manufacturing,
Sales and Marketing Practices. The policy of sale, distribution, marketing and exploitation of the Licensed Products
by LICENSEE shall be of high standard and shall in no manner reflect adversely upon the good name and reputation of LICENSOR or
any of its programs, products, properties or the Trademark. Without limiting the generality of the foregoing, LICENSEE represents
and warrants that:

 

(a)          LICENSEE
will at a minimum comply with the legal requirements and standards of its industry under the national laws of the countries in
which the LICENSEE does business;

 

(b)          LICENSEE
will fairly compensate its employees by providing wages and benefits that are in compliance with the national laws and prevailing
local standards in the countries in which LICENSEE is doing business;

 

(c)          LICENSEE
will maintain reasonable employee work hours in compliance with the local standards and applicable national laws of the countries
in which LICENSEE is doing business;

 

(d)          LICENSEE
will furnish employees with safe and healthy working conditions;

 

(e)          LICENSEE
will protect the environment in its manufacturing process; and

 

    	18

    	 

    

 

(f)          LICENSEE
will not employ children or forced labor in any action taken under this Agreement.

 

LICENSOR may inspect
any facility where LICENSEE makes Licensed Products to determine LICENSEE’s compliance with the Standards and
the Specifications.

 

15.         Confidentiality.

 

(a)          Obligations
of the Parties. Each party shall regard as confidential and proprietary all of the information communicated to it by the other
in connection with this Agreement (which information shall at all times be the property of the disclosing party) ("Confidential
Information"). The other party shall not, without the disclosing party’s prior written consent, at any time (i) use
such information for any purpose other than in connection with the performance of its obligations under this Agreement or
(ii) disclose any portion of such information to third parties, excluding agents or subcontractors which are directly performing
services for or in connection with this Agreement. Upon the expiration or earlier termination of this Agreement,
each party shall promptly return to the other, without retaining copies thereof, all such information. The parties shall cause
each of their employees, agents and subcontractors who have access to such information to comply with the terms of this Section 15
in the same manner as the parties are bound hereby, with each party remaining responsible for the actions and disclosures of its
employees, agents and subcontractors. The parties agree that any breach of this Section 15 by a party or its employees,
agents or subcontractors could cause irreparable injury for which the disclosing party may be entitled to specific performance
and injunctive or other equitable relief as a remedy for any such breach.

 

(b)          Exceptions.
Notwithstanding the foregoing, the parties’ obligations pursuant to Section 15(a) above shall not apply to (i) information
that, at the time of disclosure, is, or after disclosure becomes part of, the public domain other than as a consequence of any
breach hereof, (ii) information that was known or otherwise available to a party prior to its disclosure, (iii) information
disclosed by a third party, if such third party's disclosure neither violates any obligation of the third party to the disclosing
party nor is a consequence of any breach hereof, or (iv) information that the disclosing party authorizes, in writing, for
release.

 

16.          Sublicenses.

 

(a)          Grant
of Sublicense. LICENSEE shall have the right to grant sublicenses of its rights under this Agreement to its controlled
subsidiaries (only for so long as such subsidiaries remain controlled by LICENSEE), subject to LICENSOR’S written approval
and as set forth on Schedule 16(a).

 

(b)          Approved
Sublicensees. Schedule 16(a) lists all of LICENSEE’S approved sublicensees (“Approved Sublicensees”).

 

(c)          Sublicensee
Territory. LICENSEE shall authorize each sublicensee to sell only in its licensed territory and shall prohibit sublicensees
from soliciting sales outside its licensed territory, subject to applicable law.

 

(d)          Guarantee.
LICENSEE hereby guarantees the proper performance of the terms and conditions of each such sublicense by its Approved Sublicensees.

 

    	19

    	 

    

 

(e)          Notice
of Sublicense. LICENSEE shall give LICENSOR prompt written notice of the execution of any sublicense agreement and, at the
same time, give LICENSOR a copy of the complete, signed agreement. LICENSEE shall record such sublicenses at its own expense in
those countries where doing so is necessary or desirable to protect the sublicensed trademark rights; provided, that in
the event LICENSEE does not do so, LICENSOR retains the right to record the sublicenses at LICENSEE’s expense.

 

(f)          Form
of Sublicense. The agreed form of sublicense is attached hereto as Schedule 16(b). In the event either LICENSEE
or LICENSOR determines that a particular jurisdiction requires a modified form of sublicensee, LICENSEE and LICENSOR shall use
their reasonable best efforts to negotiate in good faith the terms of the modified form of sublicense agreement. In the event such
sublicense agreement has to be modified to conform to any local law, LICENSEE may submit to LICENSOR for approval a form of sublicense
(on a country-by-country basis) that as closely as possible conforms to Schedule 16(b) and being consistent with local law
along with an explanation as to why such changes are required by local law. To the extent permitted by local law, each such sublicense
shall be retroactively effective as of the date of their creation.

 

(g)          Third
Party Beneficiary. The parties acknowledge that LICENSOR is a direct third party beneficiary of LICENSEE’s sublicenses
with respect to the Licensed Products. LICENSOR shall have the right, independent of LICENSEE, to require performance by
any Approved Sublicensee of the terms and conditions of the sublicense agreement and to bring all causes of action
that result from breach of those terms and conditions by the Approved Sublicensee.

  

17.         General
Provisions.

 

(a)          Force
Majeure. The performance by either party of any of its obligations under this Agreement (excluding obligations to make
payments due and owing hereunder) may be suspended by it, in whole or in part, if a Force Majeure Event prevents such performance.
Upon the occurrence of a Force Majeure Event, the party whose performance is affected shall notify the other party as soon
as is reasonably practicable giving the full relevant particulars and shall use its reasonable efforts to remedy the situation
as soon as practicable.

 

(b)          Notice.
Any notice required or permitted by this Agreement shall be in writing and shall be sent by (i) means that provides
documentary evidence of receipt, including facsimile, recognized commercial overnight courier, United States registered or certified
mail, addressed to the other party at the address shown on the cover page of this Agreement or to such other address as
may be provided in writing by either party hereunder. Any notice or other communication shall be effective only if given in writing,
and shall be effective as of the date evidenced by a delivery receipt if personally delivered or sent by facsimile, overnight courier,
or certified or registered mail.

 

(c)          Governing
Law and Jurisdiction. The construction and performance of this Agreement shall be governed by the internal, substantive
laws of the State of Wisconsin without regard to its choice of law rules and each party submits to and agrees to bring all claims
under this Agreement in the exclusive jurisdiction of the Federal or State Courts of Wisconsin.

 

    	20

    	 

    

 

(d)          Export
Control. LICENSEE acknowledges that it is familiar with, and shall in connection with its operations under this Agreement
comply in all respects with U.S. laws, regulations and administrative requirements applicable to this Agreement concerning
the export or re-export of any Confidential Information, or any United States origin product, software, or technology, or
the direct product thereof, including, but not limited to, the International Traffic in Arms Regulations, the Export Administration
Regulations, and the regulations and orders issued and/or administered by the U.S. Department of the Treasury, Office of Foreign
Assets Control in relation to export control, anti-boycott and trade sanctions matters. LICENSEE shall be responsible for obtaining
any required United States government authorizations, as applicable, including, but not limited to, export licenses or exemption
authorizations, applicable to its operations under this Agreement.

 

(e)          Binding
Effect. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their successors and
assigns.

 

(f)          Intentionally
Omitted.

 

(g)         Assignment.
This Agreement, and the license granted hereunder by LICENSOR, is indivisible, non-severable and strictly personal to LICENSEE.
LICENSOR has entered into this Agreement on the terms and conditions set forth herein based on an expectation of personal
performance by LICENSEE. As a result, the parties agree that LICENSEE shall not, directly or indirectly including by operation
of law, assign, delegate or otherwise transfer this Agreement, in whole or in part, or any rights, privileges, duties and
obligations hereunder without the prior written consent of LICENSOR, which consent may be withheld at LICENSOR’s sole discretion.
Any attempted assignment, delegation or transfer in violation of this Section shall be null and void and of no force or effect
and shall give LICENSOR the right to terminate this Agreement immediately on written notice to LICENSEE. LICENSEE shall
not have the right to use this Agreement or the Trademark(s) as collateral or other security and any attempt to do
so in violation of this Section shall be null and void and of no force or effect and shall give LICENSOR the right to terminate
this Agreement immediately on written notice to LICENSEE. LICENSOR may assign this Agreement (and all of its rights
and obligations hereunder) to any entity with or into which it merges or reorganizes, to any purchaser of the business relating
to the Trademarks or to any current or future LICENSOR parent, subsidiary or affiliate. This Agreement shall be binding
upon and inure to the benefit of the parties hereto and their permitted assigns.

 

(h)          Severability.
Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under
applicable law, but if any provision of this Agreement shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity without invalidating the remainder of such provision or the remaining
provisions of this Agreement.

 

(i)          Merger/Amendment.
This Agreement and any documents incorporated by reference herein constitutes the entire agreement and understanding between
the parties regarding the subject matter hereof, and supersedes and merges all prior discussions and agreements between them relating
thereto. No waiver, modification or amendment to this Agreement shall be valid unless in writing, signed by the parties
hereto. No usage of trade or course of dealing between or among any persons having any interest in this Agreement shall
be deemed effective to modify, amend, or discharge any part of this Agreement or any rights or obligations of any party
hereunder.

 

    	21

    	 

    

 

(j)          Independent
Contractors. Nothing contained herein shall be deemed or construed to create any partnership or joint venture between LICENSOR
and LICENSEE. All activities by LICENSEE or its subcontractors under the terms of this Agreement shall be carried on by
LICENSEE or its subcontractors, as an independent contractor and not as an agent for or employee of LICENSOR. Under no circumstances
shall any employee of LICENSEE or employee of its subcontractors be deemed or construed to be an employee of LICENSOR. LICENSOR
shall not be liable for any injuries or damages incurred by LICENSEE, or its subcontractors, as a result
of its activities in the performance of this Agreement.

 

(k)          No
Public Disclosure. The parties acknowledge that LICENSEE is a publicly-held entity and, as such, is legally required to make
disclosure of the existence of this Agreement and certain material facts relating to this Agreement, LICENSEE’S
performance thereunder, and the Licensed Products. LICENSEE represents that such public disclosure includes, (i) the filing
with the Securities and Exchange Commission of required reports and exhibits thereto, (ii) the issuance of press releases disclosing
material information and (iii) the disclosure of material information in presentations, reports, and annual reports to analysts,
investors and the investment community; but that such disclosures will be limited to (A) the date on which the Agreement
was entered into or amended or terminated, the identity of the parties to the Agreement or amendment, and a brief description
of any material relationship between the Licensee or its Affiliates and the LICENSOR other than in respect of the Agreement
or amendment; (B) a brief description of the terms and conditions of the Agreement or amendment that are material to the
LICENSEE, (C) Licensed Product descriptions and related customer and sales information, and (D) if so required, a redacted
version of the Agreement. In each such instance, LICENSEE agrees to provide to LICENSOR, five (5) business days (unless
an earlier response is required by SEC rules and regulations) in advance of the release or issuance thereof, any and of all such
filings, presentations, press releases, reports, statements, redacted form of Agreement and all other public disclosures
for the advance review and approval of LICENSOR, which approval shall not be unreasonably withheld. None of such items shall be
deemed to be Advertising Materials hereunder.

 

With respect to all other public disclosures
not covered in the preceding paragraph, neither party shall make any press release or other public statement or announcement concerning
the existence of this Agreement or its terms, the business relationship between the parties or the transactions contemplated
hereby, without the prior written approval of the other party. In that regard each and all of the following (unless governed by
the preceding paragraph) shall be subject to LICENSOR’S prior review and written approval: (i) all written statements, responses
and other correspondence directed by LICENSEE to any third party (including, without limitation, governmental agencies and non-governmental
organizations) pertaining to LICENSOR and/or any Licensed Product or Trademark; (ii) all materials prepared by LICENSEE
in connection with media interviews, newsletters, trade show presentations and other external presentations pertaining to any Licensed
Product, Trademark and/or the transactions contemplated by this Agreement (as well as, in the case of interviews and
presentations, the decision as to who will engage in the interview or conduct the presentation). LICENSEE acknowledges that LICENSOR
may, in the exercise of its approval rights under this paragraph, prohibit a particular statement or the use of particular materials
altogether.

 

(l)          Waiver.
The failure or delay of either party to insist upon the other party's strict performance of the provisions in this Agreement
or to exercise in any respect any right, power or remedy provided for under this Agreement shall not operate as a waiver
or relinquishment thereof, nor shall any single or partial exercise of any right, power or remedy preclude other or further exercise
thereof, or the exercise of any other right, power or remedy; provided, however, that the obligations and duties of either party
with respect to the performance of any term or condition in this Agreement shall continue in full force and effect.

 

    	22

    	 

    

 

(m)          Counterparts.
This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall
constitute the entire agreement.

 

(n)          Survival.
The provisions of Sections 2(b), 5(d), 5(e), 6(e), 6(f), 6(g), 9(b), 11, 12, 13(c),
13(d), 13(e), 13(f), 13(g), 15, 16, 17(b), 17(c), 17(e), 17(f), 17(g), 17(h), 17(i), 17(k), 17(l), 17(n), and 18
herein shall survive any termination or expiration of this Agreement. 

 

(o)          Agency
Representation. LICENSEE acknowledges that International Marketing Concepts, LLC ("IMC"), a Kentucky limited
liability company with its principal place of business in Louisville, Kentucky, represents LICENSOR with respect to this Agreement.

 

(p)          Safety/Health/Environment.
LICENSEE shall comply with, and shall cause each of the Manufacturers to comply with, all applicable workplace Safety, Health,
Environmental laws, rules, regulations, and industry standards. LICENSEE shall allow, and shall cause each of the Manufacturers
to allow, LICENSOR to conduct an S/H/E audit and agree to take action on the results of such audit.

[Signature Page to follow]

 

    	23

    	 

    

 

IN WITNESS WHEREOF, the parties have caused
this Agreement to be executed as of the Effective Date.

 

	S. C. JOHNSON & SON, INC.	 	CTI INDUSTRIES CORPORATION
	 	 	 
	By:	 	 	By:	 
	 	 	 	 	 
	Name:	 	 	Name:	 
	 	 	 	 	 
	Title:	 	 	Title:	 

 

SCJ Matter No.:

 

    	24

    	 

    

 

EXHIBIT A

 

TRADEMARKS

 

''''''''''' ''''''''''

'ZIPLOC'
''''''''''''''''''' '''''' '''''''''''''''''' '''''''' '''''''''''''

'''''''''''''''' '''''''''''''''''''
'''''' ''''''''''''' ''''''''''''''''' '''''''''''''

 

'''''''''' '''''''

''''''''''''''''' ''''''''''''''''''''
'''''' ''''''''''' '''''''' ''''''''''''

'''''''''''''''' '''''''''''''''''''''
''''' '''''''''' '''''''''''''''' ''''''''''''

 

''''''''''''

'''''''''''''' '''''''''''''''''
'''''' ''''''''''''' ''''''''' ''''''''''

'''''''''''''' '''''''''''''''''''''
'''''' '''''''''''' '''''''''''''''''' ''''''''''

 

'''''''''''''

'''''''''''''' ''''''''''''''''''
'''''' ''''''''''''' '''''''' '''''''''''''

''''''''''''''' ''''''''''''''''''''
'''''' ''''''''''' '''''''''''''''' '''''''''''

  

    	25

    	 

    

 

EXHIBIT B

 

MANUFACTURER LETTER AGREEMENT

 

[insert mailing date]

 

Manufacturer

<Address>

 

RE:     Approval for Third-Party Manufacturer

 

Gentlemen/Ladies:

 

This letter shall serve
as notice to you that, pursuant to Section 4 of the Trademark License Agreement (the “Agreement”) dated __________________,
200___, between ____________________ (“Licensor”) and ________________________ (“Licensee”), we have been
engaged by Licensee as the manufacturer of the following Licensed Products: [insert relevant Licensed Products]. We represent that
we have received and reviewed a redacted copy of the Agreement and shall comply with the obligations set forth in the Agreement
that are applicable to “Manufacturers” of Licensed Products (including, but not limited to, those set forth in Section
6(h) of the Agreement). We further agree that our use of any Licensor trademarks, service marks, other corporate indicia, or other
intellectual property is strictly limited to and governed by the terms of the Agreement.

 

We agree that our engagement
by Licensee as the Manufacturer of the Licensed Products identified above is subject to your written approval. We request, therefore,
that you sign in the space below, thereby consenting to such engagement.

 

	 	Sincerely,	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	On behalf of:  [insert Manufacturer name]
	 	Address:	 	 
	 	 	 	 
	 	 	 	 

 

AGREED TO AND ACCEPTED:

 

	Licensor:	 
	 	 
	By:	 	 	 
	Name:	 	 	 
	Title:	 	 	 
	Date:	 	 	 

 

    	26

    	 

    

 

EXHIBIT C

 

ROYALTY REPORT

 

(See attached)

 

    	27

    	 

    

 

 

    	28

    	 

    

EXHIBIT D

 

CONTACTS

 

	Matter Type	 	Contact Person
	 	 	 
	
        General Matters

        Notices
	 	'''''''''' ''''''''''''''''''''' ''''''''''''''''''''''
	
        Renewal/

        Termination

        Inquiries

        Samples

         
	 	
        '''''''''''
        ''''''''''''''''''''''' 

 

        '''''''' ''''''''''' '''''''''''''''

        '''''''''''''''''''''''
        ''''''''' ''''''''''''''

         

        '''''''' ''''''''''''''''''''''''''''''''''

        '''''''''''' '''''''''''''''''''''''''''''''
        

        '''''''''' '''''''''''''''''''''''''''''''''''

        '''''''''''''''' '''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''

        
	
        '''''''''''''
        ''' ''''''''''' '''''' 

 

        ''''''''''''''''' ''''
        ''''''''''''''''

        '''''''''''''''''''''
        ''' '''''''''''''' ''''''''''''' ''''''''''''''''''''''

        ''''''''' ''''''''''''''''''
        ' '''''''''' ''''''''''

        '''''''''' '''''''''''''
        ''''''''''''

        ''''''''''''''''''
''''''' ''''''''''''''

 

        ''''''''''' '''''''''''''''''''''''''''''''

        ''''''''''' '''''''''''''''''''''''''''''''

        '''''''''' ''''''''''''''''''''''''''''''

        '''''''''''''''''''''''''''''''''''''

	 	 	 
	Certificates Of Insurance	 	
        ''''''''''''
        '''''''''''''''''''

 

        '''''''''''''' '''''''''''''''''''

        ''''''''''' ''''''''''''''''''''
        

        ''''''''' ''''''''''''
        '''''''''''''

        '''''''''''''''''''''''''''
        '''''''' '''''''''''''

        '''''''''' ''''''''''''''''''''''''''''''
        

        '''''''''' '''''''''''''''''''''''''''''''
        

        '''''''''''''' '''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''

	 	 	 
	
        Quality Control

        Recalls and Material Submissions
	 	
        ''''''''''''
        '''''''''''''

 

        '''''''''''''''''' '''''''''''''''''''
        '''''''''''''''''''''

        ''''''''''''' ''''''''''''''''''
        '''''''''''''''''''

        ''''''''' '''''''''''''''''''
        ' ''''''''' ''''''''''

        '''''''''''' '''''''''''''
        ''''''''''''''

        ''''''''''''''''''
''''''''' ''''''''''''''''

 

        ''''''''''' '''''''''''''''''''''''''''''''''''

        '''''''''' ''''''''''''''''''''''''''''''''''

        '''''''''''''''''''''''''''''''''''''''
	
        ''''''''''''
        '''' '''''''''''' ''''''

 

        ''''''''''''''' ''''''''''''''''''''''''''

        '''''''''''''''' '''''''''''''''''''

        ''''''''''' ''''''''''''''''''''''
        

        '''''''' ''''''''''' '''''''''''''

        '''''''''''''''''''''''''''
''''''''' '''''''''''''

 

        '''''''''' ''''''''''''''''''''''''''''''''

        ''''''''''' '''''''''''''''''''''''''''''''
        

        ''''''''''' '''''''''''''''''''''''''''''

        '''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''

	 	 	Reminder: Licensee must notify Licensor immediately of any serious quality defect, consumer complaint regarding injury or illness, product recall or regulatory compliance issues regarding the licensed product.
	 	 	 
	
        Royalty and

        Royalty Reports
	 	
        Royalties to:

        Make checks payable to IMC Licensing with an electronic confirmation
        & royalty report to:

        ''''''''''
        '''''''''''''''''''''

 

        ''''''''''' ''''''''''''''''''''''''
        ''''''''''''''''''''''

        ''''''''' ''''''''''''
        '''''''''''''

        '''''''''''''''''''''''''
        '''''''' '''''''''''''''

        '''''''''' ''''''''''''''''''''''''''''''
        

        ''''''''''' '''''''''''''''''''''''''''''
        

        '''''''''''''''' '''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''

 

    	29

    	 

    

 

EXHIBIT E

 

'''''''''''''''''
''''''''''''''''''''''''' '''''' ''''''''''''''''''''''''''''''

 

'''''''''''''''' ''''''''''''''''''''''

 

''''''''''''''''''''
''''''''''''''''' ''''''' '''''''''''''' '''''' ''''''' ''''''''''''''''''''''''''' '''''''''''''''''' '''''''''''''''''''' '''''''''
'''''''' ''''''''''''''''''''' '''''''''''''''''' ''''''''''' '''''''''' ''''' ''''''''''''''''' ''''' '''''''''''''''''''' ''''''''
'''''''''''''''''''''''''''' ''''''''''''''''''' ''''''''''''''''''''''''''' ''''''''''' ''''''''''''''' ''''' '''''''''''' ''''''''
''''''''''''''' '''''''' ''''''''' ''''''''''''''''''''''' ''''' '''''''''''''''''''''''''' '''''''' ''''''' ''''''''''''''' ''''''

 

''''''''''''''
''''''''''''''''''''' '''''''''''''''''''' '''''''''''''' '''''''''''

 

'''''''''''''
''''''''''''''''''''''' '''''''''''''''''''''''' '''''''''''

 

''''''''''''
'''''''''''' '''''''''''''''''''''''' '''''''' ''''''''''''''' ''''''''''

 

'''''''''''''''
''''''''''''' ''''''''''''''''' '''''''''''''''''''' ''''''''' ''''''''''''''''''''''''''' '''''''''''''''''''''''''''''''' ''''''''
'''''''''''''''''''' ''''''''' ''''' '''''''''''''

 

''''''''''''''''''''''''''''
''''''''''''''''''' '''''''''''''''' ''''''''' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''' ''''''''''''''''''''''
'''''' ''''' ''''''''' '''''' ''''''''''''''''''''' '''''''''''' ''''''''' '''' '''''''''''' ''''''''

 

'''''''''''''''''''''''''
''''''''''''''''''' '''''''''''''' '''''''''' ''''''''''''''''''''' ''''''''' '''''''' '''''''''''' ''''''''''''''''' '''''''''''''''''''''''''
'''''''''''''''''''' ''''''''''''' '''''''''''''' ''''''''''''''' ''''''''''''' '''''''''''''''' '''''''''''' '''''''' ''''''''''
''''''''''''''''''''''''''' '''''' ''''''''''''''''''''''''''''''''''

 

 

''''''''''''''''''
''''''''''''''''''''''''''''''''''

 

'''''''''''''''''''''''''''''''''''''
'''''' '''''''''''''''''''''''' ''''''''''''''''''''''''' ''''''''' ''''''''''''''''' '''''''''''''''''''''''' ''''' '''''''' '''''''''''''''''''''
'''''''''''''''''''' ''''''''' ''''''' ''''''''''''' ''''''''''''''''''''''' ''''''''''''''' ''''''''''''' '''''''''' '''''''''''''''''
'''''''''''''' ''''''''''' ''''' '''''''' '''''''''''''''' '''''''''''''''' ''''''''

 

'''''''''''''
'''''''''''''''' ''''''''' ''''''''''''' '''''''''''''''''''''''''''''' ''''''''''''''''''' ''''' '''''''''''''''''''''''' ''''''''''''''
'''''' '''''''' '''''''''''''''''''' '''''''''''''''''''''''

 

'''''''
'''''''''''''''''''''''''''''''' ''''' '''''''''''''''''''''''' '''''''''' '''''' ''''''''''''' '''''''''''''''''''' ''''''''''
'''''' ''''''''''''''''' ''''' '''''''' ''''''''''''''''''''' ''''' ''''''''''''''' '''''''''''''''''''''''''' '''''''''' '''''''''''''''''''''''

 

    	30

    	 

    

 

 

    	31

    	 

    

 

 

    	32

    	 

    

 

 

    	33

    	 

    

 

EXHIBIT F

 

''''''''''''''''''''
'''''''''''''''''''''''' '''''''''''''''''''''''''

 

''''''' ''''''''''''''''''''''' ''''''''''''''''' ''''''''' '''''''' '''''''''''''''''''
'''''''''''''''''''' ''''''''''''''''' ''''''''''''''' '''''''''''''' '''''''' '''''''''''''''''' ''''''' ''''''''''''''''''''''
'''''''''''''''''''''''' ''''''''''''''' '''''''''''''''''''' '''''''''''' '''''''''''''''''''''''''''' 

 

''''''''''''
''''''''''''''''''''' '''''''''''' '''''' ''''''''''''''''''''' ''''' '''''''''''''' ''''''''''' '''' '''''''''''''''''''''''''''''

 

'''''''''''
'''''''''''''''''''''''' ''''''''''''''''''''''''' ''''''''''' ''''' ''''''''' '''''''''''''''''''''''' ''''''''''''''''''' ''''''''
''''''''''''' ''''''''''''''''''' '''''''''''' '''''' ''''''''''''''''''''' 

 

'''''''''''''''''''
'''''''''''''''' '''''' ''''''''''''''''' '''''''''''''''''''''''''''''''' ''''''''''''''''''''''''''' '''''''''''''''''' ''''''''''''''''''''
''''' '''''''''''''''' '''' '''''''' ''''''''''' ''''''''''''''''' ''''''''''''''''''''''''''' ''''''''''''''''''''''''''''

 

'''''''''''''''''''
'''''''''''''' '''''''' '''''''''''''''''''' '''''''''''''' ''''''''''''''' '''''''''''''''''''''''''''''''' '''''''''''''' '''''
''''''' '''''''''''''''''''''''' '''''''' '''''''''''' ''''''''''''''''''' ''''''''''' '''''''''' ''''''' ''''''''''''''''''' '''''''''''
'''''''''''''''''''''' '''''''''''''''' '''''''''''''' ''''''''''''''' '''''''''''''''''

 

'''''''''''''''''''''
''''''''''''''''' '''''''''' '''''''''''''''''''''' ''''''''''''''''' '''''''''''''''''''''''''' '''''' ''''''' ''''''''''''''''''''''''
''''''' ''''''''''''''''''''''' ''''''''''''''''' '''''''''''''''''''''''

 

		§	''''''''''''' ''''''''''' '''''' '''''''''''''''' ''''''''''''''''
''''' ''''''''''''''''' '''''''''' '''' '''''''''''''''''''' '''''''''''' ''''''''''''''''''''''''''''' ''''''''' ''''''''''
'''''' ''''''''' '''''''''''''''''''''''''' '''''''''' '''''''' ''''''''''''''''' ''''''''''''''' '''''' ''''''''''' '''''''''''''''''''''''''
'''''''' '''''''''''''''''''''''''' 

 

''''''''''''''''''
'''''''''''''' '''''''''' ''''''''''' ''' '''''''''' ''''''''''''''''''' ''''' ''''''' '''''''' ''''''''''''''''''''''''' ''''''''''''''
'''''''''''' ''''' '''''''' ''''''''''''''''''' ''''''''''''''''''''''''' ''''''' '''''''''''''''''''''''''''' ''''' ''''''' '''''''''''''''''''''
'''''''''' '''' ''''''''''''''''''' '''''''' '''''''''' '''''' ''''''''''''''''' '''' '''''''''' ''''''''' '''''''''''''''''' '''''''
''''''''''''''''''' ''''''''''''''''''''''''''' ''''''''''''''''' 

 

''''''''''''''''''''
''''''''''''''''' ''''''' ''''''''''''''''''''' ''''''''''''''''''''''' '''''''''''' ''''''' '''''' '''''''''''''''''''''' '''''''''
'''''''''''''''''''''

  

		§	'''''''''''''''''' '''''''''''''''''' ''''' '''' ''''''''''' '''
''''''''''''' '''' '''''''''' ''''''''''''' '''''''''''''''' ''''''''' '''''''''''' ''''''''''''''''''''''''''' ''''''''
''''''''''''''''''''' ''''''''''''''''''''' ''''''''''''''''''''''' '''''''''''''''''' '''''''''''' '''''' ''''''''''''''''''''''''''''
'''''''''''' ''''' ''''''''''''''''''''''''''''' ''''''''''''''''''''''''' ''''''''''''' '''''''''''' ''''''' ''''''''''''''''''''''
''''''''''''''''' '''''''' '''''''''' '''''''''''''''''''' '''''''''' ''''''' '''''' ''''''''''''''''''''''''' 

 

'''''''' '''''''''''
''''''''''''' ''''''''''''' ''''''' ''''' '''''''''''''''' ''''' '''''''' '''''''''' '''''' '''''''''''''' ''''''' ''' ''''''''''''''''
''''''''''''''' ''''''''''' '''''' ''''' ''''' ''''''''''''' '''''''' '''''' '''''''''''' '' '''''''''''' '''''''''''''''''''''''''''''''''''''''''
'''''''''''''''' 

 

    	34

    	 

    

 

'''''''''''' '''' ''''''''''''

'''''''''' ''''''''''
'''''''''''''''' '''''''''''''''''' ''''''''''''''''''' ''''''''''' ''''''''''''''''''' '''''''' '''''''''' '''''''''''' '''''
'''''''''''''' ''''''''' '''''''''''''''' ''''''''''''''''''''' '''''' '''''''''''''''''''''' ''''''''' ''''''''''''''''''' ''''''''''''''
''''''''''''''''' ''''' ''''''''''''''''''''''''''''''''''''' '''''''' '''''''' ''''''' ''''''''''''''''''' '''''''''''''' '''''''''''''''''
''''''''''''''''''''' '''''''''''''''''''''''''''''''' ''''''''' ''''''''''''' '''''''''' ''''''''''''''''' ''''' ''''''''''''''''
'''''''' ''''''''''''''''''''''' '''''''''''''' '''''''''''''''' ''''''''''''''''''' ''''''' ''''''''''''''''''''' '''''''''''''''''''''''''''''''''
''''''''''' ''''''''''''''''''' '''''''' '''''' '''''''''''''''''''' ''''''''''''' ''''''''''''''' ''''' ''''''''''''''''''' '''''''''''
'''''''' '''''''''''''' '''''''''''''''''''''

 

'''''''''''' ''' '''''''''''''''''''''''''''

'''''''''''''''''''''''''''''''''''''
''''''''''''''''''' '''''''''''''' ''''''''''''''' ''''''''''''''''''''' '''''''''''''''''''' ''''''' '''''''''''''''' '''''''''''''''''''
'''''''''' '''''' '''''''''''''''''''''' '''' ''''''''' '''''''''''' ''''''''''''''''''''''''''''''''''' '''''''''''''''''''''''''
''''''''''''''''' ''''''''''''''''''' ''''''''''''''' '''''''''''' ''''''''''''''' '''''''''''''''''' ''''''''''''''''''''''' '''''''''''''''''
'''''''''' '''''''''''''''''''''''''' ''''''' ''''''''''' '''''''''' ''''''''''''' ''''''''''''''''' '''''''''''' '''''''''' '''''''''''
'''''''''''' ''''' ''''''''''''''''''' '''''' ''''''' ''''''''''''''''''''' 

 

''''''''''''' ''''
''''''''''''' ''''''''''''

''''''' ''''''''''''
''''''''''''''' '''''''' '''' '''''''''''''''' ''''' ''''''''''' '''''''''''''' '''''''' '''' '''''''''''''''' ''' ''''''''''
''''''''''''''''''''' ''''''' ''''''' '''''''''''''''''''''''''' ''''' ''''''''''''''''''''' ''''''''' ''''''''''''''''' '''''''
''''''''''''''' ''''''''''' ''''''''''' ''''''' ''''''''''''''''''' '''''''''''' '''''''''''''''''' ''''''''''''''''''''''' '''''''''''''''''''''''''''''''
'''''''' '''''' '''''''' '''''''''''''' ''''''''''''''''''' '''''''''''''''' '''''''' '''''''''' '''''''''''''''''''''''' ''''''''''
'''''' ''''''''''''''''''''''''' '''' '''''''' '''''''''''' ''''' ''''''''''''''''''''''' '''''''''''''''' '''''''''''''''''' '''''''''''
''''''''''''''''''''''''''' '''''''''''''''''' ''''' '''''''''' '''''''''''''''''' '''''''''''''''' ''''' ''''''''''' ''''' ''''''''''
''''''' '''''''''''''''''''''' '''''''''''' ''''''''''' '''''''' '''''''''''''''''' '''''''''''''''' ''''''''' '''''''''''''''
''''''' '''''''' ''''''''''''''''''''''''' 

 

''''
''''''''' '''''''''' '''''''''' '''''''''''''''''''' ''''''''''''''''''''' '''''''' '''''''''''''''''''''' '''''''''''''''''''
'''''''''''''' '''''''''''''''''

 

'''''''''''
'''''''''''''''''''' '''''''''''''''''''''

''''''''
''''''''''''''

''''''
''''''' ''''''''''

''''''''''''''''
''''''' ''''''''''

''''
''''''''' '''''''''''''' 

 

    	35

    	 

    

 

EXHIBIT G

 

''''''''''''''''''''''''''''''
'''' '''''''''''''''' '''''''''' ''''' ''''''''''''''' ''''''''''''''''''''''' '''''''''' ''''' '''''''''''''''''''''''''''

 

    	36

    	 

    

 

EXHIBIT H

 

''''''''''''''''''''''''

 

  

    	37

    	 

    

 

EXHIBIT I

 

ARTWORK ASSIGNMENT AGREEMENT

 

IN CONSIDERATION OF One Dollar ($1.00)
and other good and valuable consideration paid or to be paid to ___________________________________ (the "Contractor")
by ________________________________ ("Company"), the parties hereto agree as follows:

 

		(a)	Contractor represents and warrants that Contractor shall create all _____________ to be submitted
by Contractor hereafter to Company, including, without limitation, all _______________________ and _____________________ done and
to be done in connection with a property of ______________________________ known as ________________________. (All such materials
created by Contractor and all drafts, outlines, and other preparatory materials shall collectively be called the "Work"
herein). Contractor warrants and represents that the Work shall be original with Contractor and shall not infringe the rights of
any third parties; and that has the exclusive right forever and throughout the universe to exploit the Work and the results and
proceeds of Contractor's services rendered in connection therewith.

 

		(b)	The Work is and shall be considered a work made for hire for ___________________ and _______________
owns and shall own all right, title and interest in and to the Work and the results and proceeds of Contractor's services rendered
in connection therewith, including, without limitation, all copyrights and renewals and extensions of copyright therein.

 

		(c)	To the extent that any such ownership in such Work does not vest in __________________ by reason
of Contractor's status as an employee for hire: Contractor hereby assigns and transfers in whole to _______________, all
right, title, and interest in and to such Work and the results and proceeds thereof to the extent that Contractor has, had, or
shall have any interest therein, including without limitation, all copyrights and renewals and extensions of copyright therein.

 

		(d)	The Work may be registered for copyright in the name of _________________________, and shall own
and possess all physical material in which or on which the Work is embodied or reproduced, by or on behalf of Contractor.

_________________ shall
have the exclusive right forever throughout the universe to change, adapt, modify, use, combine with other material, and otherwise
exploit the Work in all media and by all means, whether now known or hereafter invented or developed. Contractor hereby waives
any and all claims that Contractor may have now or may hereafter have in any jurisdiction to so-called "moral rights"
or "droit moral" with respect to the Work, and to the results and proceeds thereof.

 

		(e)	Any further compensation paid or to be paid to Contractor for services rendered in connection with
the Work shall be described in a separate writing or writings. This Agreement shall constitute the entire understanding between
the parties. This Agreement may not be altered, modified or changed in any way without the express written consent of both parties
and shall be construed in accordance with the laws of the State of Wisconsin applicable to agreements executed and wholly performed
therein.

 

    	38

    	 

    

 

		(f)	When requested by Company, Contractor shall perform all such acts and things and sign all documents
and certificates which the Company may reasonably request in order to carry out the intent and purpose of this Agreement.

 

IN WITNESS WHEREOF, the undersigned have
executed this Agreement.

 

	COMPANY:	 	CONTRACTOR:
	 	 	 	 	 
	By:	 	 	By:	 
	 	 	 	 	 
	Its:	 	 	Its:	 
	 	 	 	 	 
	Date:	 	 	Date:	 

 

[to be notarized]

 

    	39

    	 

    

 

EXHIBIT J

 

MARKETING PLAN

 

LICENSEE will commit to the following marketing
support for the Licensed Products:

 

Contract Year 1: LICENSEE will spend ''''''''''''''''''''
to market the Licensed Products.

 

Contract Years 2-3:  LICENSEE will commit
to spending at least '''''''' of projected Sales to market the
Licensed Products.

 

Marketing to include one or more of the following: 
in-store promotions, POP, trade marketing, FSI, internet/social media, consumer research, possible joint advertising efforts, broadcast
commercial/infomercial, and development of a website that will provide consumer education, special promotions and potential DTC
sales.

 

    	40

    	 

    

  

SCHEDULE 16(a)

 

APPROVED SUBLICENSEES

 

Flexo Universal S.A. de C.V.

 

    	41

    	 

    

 

SCHEDULE 16(b)

 

FORM OF SUBLICENSE

 

SUBLICENSE AGREEMENT

 

This Sublicense Agreement
is entered into as of this ______ day of _________, 2011 between CTI Industries Corporation (“CTI”) and __________________
(“Sublicensee”).

 

WHEREAS, CTI and S.
C. Johnson & Son, Inc. have entered into that certain Trademark License Agreement effective as of December 9, 2011 (the “Master
Agreement”, a copy of which is attached hereto as Exhibit A), pursuant to which CTI is licensed a certain “Trademark”
related to “Licensed Products” (as both terms are defined in the Master Agreement);

 

WHEREAS, CTI has the
right to grant to certain parties sublicenses of the Trademark, subject to all restrictions and obligations set forth in the Master
Agreement;

 

WHEREAS, one of the
sublicense restrictions in the Master Agreement is the requirement that all sublicensees agree to be bound by the terms of the
Master Agreement; and

 

WHEREAS, the parties
hereto each desire that Sublicensee become an “Approved Sublicensee” as defined in the Master Agreement of the Trademark
pursuant to Section 16 of the Master Agreement.

 

NOW, THEREFORE, CTI
and Sublicensee agree as follows:

 

1.          CTI
hereby grants to Sublicensee a sublicense under the Trademark granted to CTI under the Master Agreement during the term thereof,
solely as necessary in connection with the manufacturing, marketing, promoting, distribution and sale of Licensed Products set
forth in Exhibit B hereto, and solely within the territory set forth in Exhibit B hereto.

 

2.          Sublicensee,
in its capacity as an “Approved Sublicensee” (as defined in the Master Agreement), hereby acknowledges that it has
read the Master Agreement set forth in Exhibit A and agrees to abide and be bound by all of the covenants, obligations and
restrictions and legal governance terms therein that specifically bind Sublicensees and also those terms that bind CTI. Sublicensee
hereby agrees to assume, perform and abide by all of the covenants, obligations and restrictions of CTI and of Approved Sublicensees
under the Master Agreement as direct obligations to CTI and also to S. C. Johnson & Son, Inc., including but not limited to
all license restrictions, non-competition and other covenants, and all royalty or other payments required in connection with the
Licensed Products set forth in Exhibit B.

 

3.          Sublicensee
may not assign or otherwise transfer (including by operation of law) this Agreement or its rights hereunder in whole or in part,
or delegate any of its obligations hereunder, to any third person or entity.

 

4.          Sublicensee
shall not disclose to any third person or entity any terms and conditions of the Master Agreement or of this Sublicense Agreement
without prior written consent of CTI. Sublicensee agrees that CTI may provide a copy of this Sublicense Agreement to S. C. Johnson
& Son, Inc.

 

    	42

    	 

    

 

5.          CTI
and Sublicensee acknowledge and agree that S. C. Johnson & Son, Inc. is and shall be considered an intended third party beneficiary
of all of CTI’s rights under this Sublicense Agreement with the right to enforce the same directly against Sublicensee.

 

*          *          *          *          *

 

IN WITNESS WHEREOF,
the parties hereto have executed this Sublicense Agreement as of the date first set forth above.

 

	CTI INDUSTRIES CORPORATION	 	[_________________________________________]

 

	By:	 	 	By:	 
	 	 	 	 	 
	Name:	 	 	Name:	 
	 	 	 	 	 
	Title:	 	 	Title:	 
	 	 	 	 	 
	Date:	 	 	Date:	 

 

    	43EXHIBIT 10.25

 

EXECUTION COPY

 

SECOND
AMENDED AND RESTATED

PLEDGE
AND SECURITY AGREEMENT

 

This SECOND AMENDED
AND RESTATED PLEDGE AND SECURITY AGREEMENT, dated as of February 27, 2009 (this “Agreement”), is by and among MUNIMAE
TE BOND SUBSIDIARY, LLC, a Maryland limited liability company (together with its successors and assigns, the “Pledgor”),
MERRILL LYNCH CAPITAL SERVICES, INC., a Delaware corporation (together with its successors and assigns, the “Pledgee”),
MUNICIPAL MORTGAGE & EQUITY, LLC, a Delaware limited liability company (together with its successors and assigns, the “Guarantor”),
and U.S. BANK TRUST NATIONAL ASSOCIATION, a national banking association (together with its successors and assignees, the “Collateral
Agent”).

 

W I T
N E S S E T H:

 

WHEREAS, Merrill Lynch
Capital Services, Inc., as Credit Enhancer (the “Series Q Credit Enhancer”), has delivered, and will deliver,
to the Custodian its Credit Enhancements (each, a “Merrill Lynch Credit Enhancement”) with respect to the Bonds
acquired from the Pledgor (the “Merrill Lynch Enhanced Bonds”) and deposited pursuant to the Third Amended and
Restated Custody Agreement, dated as of June 29, 2004 (the “Series Q Custody Agreement”), between Merrill Lynch
Portfolio Management Inc., as Depositor, and U.S. Bank Trust National Association, as Custodian (the “Custodian”),
relating to the Custodial Receipts, Series Q;

 

WHEREAS, each Merrill
Lynch Credit Enhancement and the Series Q Custody Agreement provide that the Series Q Credit Enhancer has the right to cause the
mandatory tender of a subseries of Custodial Receipts, Series Q issued thereunder in respect of Merrill Lynch Enhanced Bonds (the
“Applicable Series Q Custodial Receipts”) if the Value Ratio for such Merrill Lynch Enhanced Bonds has fallen
below the Minimum Value Ratio;

 

WHEREAS, MuniMae TE
Bond Subsidiary, LLC desires to provide additional security for the Series Q Credit Enhancer in respect of its obligations under
certain of the Merrill Lynch Credit Enhancements and to induce the Series Q Credit Enhancer to forbear from exercising its right
to cause a mandatory tender of Applicable Series Q Custodial Receipts by delivering the Additional Bonds and other Pledged Securities
to the Collateral Agent pursuant to this Agreement and pledging such Additional Bonds and other Pledged Securities to the Pledgee;

 

WHEREAS, Federal Home
Loan Mortgage Corporation, as Credit Enhancer (the “Series FM Credit Enhancer”), has delivered and may deliver
to the Custodian its Credit Enhancement (the “Freddie Mac Credit Enhancement”) with respect to certain bonds
(the “Freddie Mac Enhanced Bonds”) deposited pursuant to the Custody Agreement, dated as of June 5, 2008 (the
“Series FM Custody Agreement”), among Merrill Lynch Portfolio Management Inc., as Depositor, U.S. Bank Trust
National Association, as Custodian, MuniMae TE Bond Subsidiary, LLC, MuniMae TEI Holdings, LLC, Merrill Lynch Capital Services,
Inc. and Federal Home Loan Mortgage Corporation, relating to the Custodial Receipts, Series FM;

 

    	 

    	 

    
 

WHEREAS, Merrill Lynch
Capital Services, Inc. and Federal Home Loan Mortgage Corporation have entered into the Reimbursement Agreement, dated as of June
5, 2008 (the “Reimbursement Agreement”), pursuant to which Merrill Lynch Capital Services, Inc. is obligated
to reimburse the Series FM Credit Enhancer for certain payments made by the Series FM Credit Enhancer under the Freddie Mac Credit
Enhancement;

 

WHEREAS, the Series
FM Custody Agreement provides that Merrill Lynch Capital Services, Inc. has the right to cause the mandatory tender of a subseries
of Custodial Receipts, Series FM issued thereunder in respect of Freddie Mac’s Enhanced Bonds (constituting the TEBS-1 Enhanced
Custodial Receipts, the TEBS-2 Enhanced Custodial Receipts and the TEI Enhanced Custodial Receipts (each as defined in the Reimbursement
Agreement) and, herein, the “Applicable Series FM Custodial Receipts”) if the Value Ratio for the Freddie Mac
Enhanced Bonds has fallen below the Minimum Value Ratio;

 

WHEREAS, MuniMae TE
Bond Subsidiary, LLC desires to induce Merrill Lynch Capital Services, Inc. to enter into the Reimbursement Agreement, to induce
Federal Home Loan Mortgage Corporation to execute and deliver the Freddie Mac Credit Enhancement, to provide additional security
for Merrill Lynch Capital Services, Inc. in respect of its obligations under the Reimbursement Agreement and to induce Merrill
Lynch Capital Services, Inc. to forbear from exercising its right to cause a mandatory tender of Applicable Series FM Custodial
Receipts by delivering the Additional Bonds and other Pledged Securities to the Collateral Agent pursuant to this Agreement and
pledging such Additional Bonds and other Pledged Securities to the Pledgee;

 

WHEREAS, certain Series
Trust Agreements, each dated the related Date of Original Issue (each, a “Series Trust Agreement”), among Merrill
Lynch, Pierce, Fenner & Smith Incorporated, as Trustor, Merrill Lynch Portfolio Management Inc. and the Trustee and Tender
Agent that is a party to each such Series Trust Agreement (the “Trustee” and the “Tender Agent”),
incorporating by reference therein the Standard Terms and Provisions of Series Trust Agreement (the “Standard Terms”
and, together with each such Series Trust Agreement, including all exhibits, appendices, supplements and amendments thereto, a
“Trust Agreement”), provide for the delivery to the Trustee of the Bonds identified in each such Series Trust
Agreement, which Bonds are not deposited under the Series Q Custody Agreement or the Series FM Custody Agreement and are not secured
by a Merrill Lynch Credit Enhancement or the Freddie Mac Credit Enhancement (the “Unenhanced Bonds”), and the
creation, execution and delivery of the Receipts identified in each such Series Trust Agreement evidencing undivided interests
in such Unenhanced Bonds, which Receipts include RITES held by the Pledgor;

 

WHEREAS, Merrill Lynch
Capital Services, Inc., as Liquidity Provider, has entered, and will enter, into Standby Purchase Agreements, each dated the related
Date of Original Issue (each, a “Merrill Lynch Liquidity Facility”), with the Trustee and Tender Agent, in order
to provide a source of liquidity with which to pay the Purchased Price of tendered P-FLOATs issued under the Trust Agreements for
Unenhanced Bonds (the “Applicable Unenhanced P-FLOATs”) upon an optional or mandatory tender of such Applicable
Unenhanced P-FLOATs pursuant to and in accordance with the related Trust Agreement;

 

    	2

    	 

    
 

WHEREAS, pursuant to
the Ratio Tender Event Clauses, a Mandatory P-FLOATs Tender Event will occur with respect to all or a portion of a Series of Applicable
Unenhanced P-FLOATs when the P-FLOATs Ratio is below the Minimum P-FLOATs Ratio for designated time periods and Merrill Lynch Capital
Services, Inc., as Liquidity Provider, exercises its right to elect to require a Mandatory P-FLOATs Tender Event;

 

WHEREAS, MuniMae TE
Bond Subsidiary, LLC desires to create a method to avoid the occurrence of a Mandatory P-FLOATs Tender Event pursuant to the Ratio
Tender Event Clauses and to cause Merrill Lynch Capital Services, Inc, as Liquidity Provider, to forbear exercising its right to
elect to require such a Mandatory P-FLOATs Tender Event, by delivering the Additional Bonds and other Pledged Securities to the
Collateral Agent pursuant to this Agreement and pledging such Additional Bonds and other Pledged Securities to the Pledgee;

 

WHEREAS, certain Series
Trust Agreements provide for the delivery to the Trustee of Custodial Receipts, Series FM identified in each such Series Trust
Agreement and the creation, execution and delivery of the Receipts identified in each such Series Trust Agreement evidencing undivided
interests in such Custodial Receipts, Series FM, which Receipts include RITES held by the Pledgor;

 

WHEREAS, Federal Home
Loan Mortgage Corporation, as Liquidity Provider, will enter into a Liquidity Facility, dated as of June 5, 2008 (the “Freddie
Mac Liquidity Facility”), with the several Trusts identified therein and the Trustee and Tender Agent, in order to provide
a source of liquidity with which to pay the Purchase Price of tendered P-FLOATs issued under the Trust Agreements for Custodial
Receipts, Series FM (the “Applicable Enhanced P-FLOATs”) upon an optional or mandatory tender of such Applicable
Enhanced P-FLOATs pursuant to and in accordance with the related Trust Agreement;

 

WHEREAS, pursuant to
the Reimbursement Agreement, Merrill Lynch Capital Services, Inc., is obligated to reimburse Federal Home Loan Mortgage Corporation,
as Liquidity Provider, for certain payments made by Federal Home Loan Mortgage Corporation, as Liquidity Provider, under the Freddie
Mac Liquidity Facility;

 

WHEREAS, MuniMae TE
Bond Subsidiary, LLC desires to induce Merrill Lynch Capital Services, Inc. to enter into the Reimbursement Agreement, to induce
Federal Home Loan Mortgage Corporation to enter into the Freddie Mac Liquidity Facility and to provide additional security for
Merrill Lynch Capital Services, Inc. in respect of its obligations under the Reimbursement Agreement by delivering the Additional
Bonds and other Pledged Securities to the Collateral Agent pursuant to this Agreement and pledging such Additional Bonds and other
Pledged Securities to the Pledgee; and

 

WHEREAS, Municipal
Mortgage & Equity, LLC is willing to guarantee certain of the obligations of the Pledgor;

 

NOW, THEREFORE, for
good and valuable consideration, the receipt and adequacy of which are hereby specifically acknowledged, the Pledgor, the Pledgee,
the Guarantor and the Collateral Agent hereby agree as follows:

 

    	3

    	 

    
 

1.     Definitions.

 

(a)     Capitalized
terms used and not defined herein shall have the respective meanings ascribed in the Series Q Custody Agreement, the Series FM
Custody Agreement or the Trust Agreements, as applicable.

 

(b)     Unless
the context otherwise requires, the defined terms used herein shall have the meanings indicated below:

 

“Act of Bankruptcy”
shall mean, with respect to any Person, (i) a petition for involuntary bankruptcy shall have been filed against such Person,
which either shall result in an order granting the bankruptcy relief requested in such petition (including but not limited to an
order for relief under Chapter 7, 9 or 11 of the United States Bankruptcy Code, Title 11 of the United States Code, as amended)
or shall remain undismissed and unstayed for a period of 60 days; (ii) a decree or order of a court or agency or supervisory
authority having jurisdiction in the premises for the appointment of a conservator, receiver or liquidator in any insolvency, readjustment
of debt, marshalling of assets and liabilities or similar proceeding, or for the winding up or liquidation of its affairs, shall
have been entered against such Person, which shall remain undismissed and unstayed for a period of 60 days; (iii) the appointment
of, or the taking of possession by, a receiver, custodian, trustee or liquidator of such Person or of a substantial part of its
property for purposes of distributing such Person’s assets or winding up such Person’s affairs, which shall remain
unstayed for a period of 60 days; or (iv) such Person shall have: (a) commenced a voluntary action under applicable bankruptcy
laws, (b) filed a petition seeking to take advantage of any other laws, domestic or foreign, to effect such Person’s
bankruptcy, insolvency, reorganization, debt adjustment, winding up or composition or adjustment of debts, (c) consented to
or failed to contest for 60 days a petition filed against it in an involuntary case under such bankruptcy laws or other laws, (d) taken
any formal action which results in a written statement of action duly approved by an authorized committee or governing body, as
appropriate, that admits without condition such Person’s inability to make payments on its debts as they become due, (e)
generally not been paying principal of or interest on its material obligations as they become due (except as a result of a dispute
regarding such obligations), or (f) made a general assignment for the benefit of creditors.

 

“Additional
Bonds” shall mean (i) the municipal bonds previously delivered to the Collateral Agent pursuant to the Predecessor Pledge
and Security Agreement identified on Schedule 1 hereto; (ii) any other tax-exempt municipal bonds delivered to the Collateral
Agent pursuant to Section 4 hereof that have been approved by the Pledgee, which approval shall be in the sole discretion
of the Pledgee; and (iii) any interests in any of the foregoing (including Custodial Receipts, Series UR issued under the Series
FM Custody Agreement) delivered to the Collateral Agent pursuant to Section 4 hereof that have been approved by the Pledgee, which
approval shall be in the sole discretion of the Pledgee.

 

“Applicable
Custodial Receipts” means, collectively, the Applicable Series Q Custodial Receipts and the Applicable Series FM Custodial
Receipts.

 

    	4

    	 

    
 

“Applicable
Freddie Mac Enhanced Bonds” means, collectively, the bonds held under the Series FM Custody Agreement that relate to
the TEBS-1 Enhanced Custodial Receipts and the TEBS-2 Enhanced Custodial Receipts (as defined in the Series FM Custody Agreement).

 

“Applicable
P-FLOATs” means, collectively, the Applicable Unenhanced P-FLOATs and the Applicable Enhanced P-FLOATs.

 

“Boot Bonds”
means those Additional Bonds identified on Schedule 2 hereto and any additional Boot Bonds delivered and pledged hereunder.

 

“Collateral”
means (i) the Pledged Securities; and (ii) all additions and accessions to, and all substitutions or replacements for, and all
payments, Proceeds, products, distributions (whether in money, securities or other property) and collections from or with respect
to any or all of the foregoing.

 

“Credit Enhancement
Payment” means any payment made by the Pledgee pursuant to the terms of a Merrill Lynch Credit Enhancement or any payment
made by Federal Home Loan Mortgage Corporation pursuant to the terms of the Freddie Mac Credit Enhancement.

 

“Enhanced
Bonds” means, collectively, the Merrill Lynch Enhanced Bonds and the Freddie Mac Enhanced Bonds.

 

“Event of
Default” means (i) the occurrence of any event giving rise to a Mandatory Tender Date, (ii) any failure by the Pledgor
to pay its Shortfall Obligation or its Fee Obligation hereunder, (iii) any transfer by Municipal Mortgage & Equity, LLC of
any portion of its indirect ownership interest in the Pledgor without the prior written consent of the Pledgee, (iv) the occurrence
of an Act of Bankruptcy with respect to Pledgor, (v) any breach by Pledgor of any of the representations, covenants and agreements
made by the Pledgor in this Agreement or any other agreement between the Pledgor and Merrill Lynch Capital Services, Inc., to the
extent that such breach relates to the Applicable Freddie Mac Enhanced Bonds, including the payment of any Obligations hereunder,
(vi) any attempt by any Pledgor to sell, pledge or otherwise transfer any of the Pledged Securities or any interest therein in
contravention of this Agreement, or (vii) any attempt to cause any of the Pledged Securities to become subject to any Lien (other
than the Lien granted to the Pledgee under this Agreement and any Lien created under the Series FM Custody Agreement).

 

“Guaranteed
Obligations” means all Obligations other than the Shortfall Obligation, the Fee Obligation and the Put Obligation.

 

“Lien”
means any lien, charge, encumbrance, transfer restriction or other preferential arrangement of any kind or description.

 

“Market Deficiency”
means the dollar amount that, when added to the market value of any Unenhanced Bonds (determined on the basis of Quotation of Bond
Price) and divided by the related P-FLOATs Stated Amount, results in a fractional number equal to the related Minimum P-FLOATs
Ratio.

 

    	5

    	 

    
 

“Minimum Value
Ratio” means (i) with respect to the Merrill Lynch Enhanced Bonds, 140% or, with respect to the Custodial Receipt of
a particular Series, such other Minimum Value Ratio specified in the related Notice of Deposit delivered pursuant to Section 2.01
of the Series Q Custody Agreement, and (ii) with respect to the Freddie Mac Enhanced Bonds, 140%.

 

“Obligations”
means (i) the Shortfall Obligation, (ii) the Fee Obligation, (iii) the Put Obligation, and (iv) the obligation of the Pledgor to
make all other payments agreed to be made by the Pledgor under this Agreement.

 

“Pledged Securities”
means, collectively, (i) the Additional Bonds delivered by the Pledgor to the Collateral Agent under the Predecessor Pledge and
Security Agreement; (ii) the Additional Bonds delivered by the Pledgor to the Collateral Agent hereunder from time to time thereafter
in accordance with the terms hereof; (iii) any cash or Eligible Investments delivered by the Pledgor to the Collateral Agent hereunder
from time to time in such form as shall have been approved by the Pledgee, which approval shall be in the sole discretion of the
Pledgee; (iv) any letter of credit drawn in favor of the Pledgee payable upon the occurrence of a Credit Enhancer Shortfall or
Liquidity Provider Shortfall delivered to the Collateral Agent hereunder from time to time which has been approved by the Pledgee,
which approval shall be in the sole discretion of the Pledgee; and (v) any taxable loan made by the Guarantor to an obligor on
Bonds or Additional Bonds, including all security documents with respect thereto, delivered to the Collateral Agent hereunder from
time to time which has been approved by the Pledgee, which approval shall be in the sole discretion of the Pledgee. With respect
to the Boot Bonds, the Pledged Securities shall also include the related Custodial Receipts, Series UR issued under the Series
FM Custody Agreement, provided that no additional value shall be given therefor for purposes of determining if sufficient Collateral
is posted hereunder.

 

“Predecessor
Pledge and Security Agreement” means the Pledge and Security Agreement, dated as of August 30, 2001, among MuniMae TE
Bond Subsidiary, LLC, as Pledgor, Merrill Lynch Capital Services, Inc., as Pledgee, Municipal Mortgage & Equity, LLC, as Guarantor,
and State Street Bank and Trust Company, National Association, as Collateral Agent.

 

“Proceeds”
has the meaning ascribed to it under the Uniform Commercial Code as in effect in the State of New York from time to time, and,
in any event, shall include, but not be limited to, (i) any and all proceeds of any insurance, indemnity, warranty or guaranty
payable to the Pledgor from time to time with respect to any of the Collateral, (ii) any and all payments (in any form whatsoever,
including in-kind distributions of other securities) made or due and payable to the Pledgor from time to time in connection with
any requisition, confiscation, condemnation, seizure or forfeiture of all or any part of the Collateral by any Person (whether
or not acting under color of governmental authority), and (iii) any and all other amounts from time to time paid or payable under
or in connection with any of the Collateral.

 

“Ratio Tender
Event Clause” means Section 5.2(a)(ix) of the Standard Terms forming part of each Trust Agreement (or the Section containing
substantially the same provisions in Standard Terms for Series Trust Agreements subsequent to June 5, 2008).

 

    	6

    	 

    
 

“Value Deficiency”
means, with respect to any Enhanced Bonds as of any date of calculation, the positive difference, if any, derived by subtracting
(i) the principal amount of such Enhanced Bonds on such date multiplied by the Value Ratio therefor on such date from (ii) the
principal amount of such Enhanced Bonds on such date multiplied by the Minimum Value Ratio therefor on such date.

 

“Value Ratio”
means, as of any date of calculation, the percentage derived by dividing (i) the market value of the Enhanced Bonds on such date
(as determined, subject to the provisions of Section 4(f) and (g) hereof, by the Pledgee in its sole discretion) by (ii) the principal
amount of such Enhanced Bonds on such date multiplied by, in the case of the Merrill Lynch Enhanced Bonds, the Credit Enhancement
Principal Coverage Factor on such date.

 

2.     Shortfall
Obligation and Other Obligations.

 

(a)     If
either (i) the Pledgee makes any Credit Enhancement Payment and thereafter receives proceeds from the liquidation of Merrill Lynch
Enhanced Bonds pursuant to the terms of the Series Q Custody Agreement in an amount less than the amount of such Credit Enhancement
Payment, or (ii) to the extent that such amounts relate to the Applicable Freddie Mac Enhanced Bonds, either (A) Merrill Lynch
Capital Services, Inc. has paid or owes any money under the Reimbursement Agreement in connection with the Freddie Mac Credit Enhancement
for which its has not been reimbursed by the Pledgor or one of its affiliates, or (B) after the First Loss (as defined in the Reimbursement
Agreement) has been reduced to zero, Federal Home Loan Mortgage Corporation makes any Credit Enhancement Payment and thereafter
receives proceeds from the liquidation of Freddie Mac Enhanced Bonds or interests therein pursuant to the terms of the Series FM
Custody Agreement in an amount less than the amount of such Credit Enhancement Payment, then, in any such case, the Pledgor hereby
agrees to pay such deficiency or amount paid or owing (a “Credit Enhancer Shortfall”) to the Pledgee as provided
herein.

 

(b)     If
either (i) the Pledgee or Merrill Lynch, Pierce, Fenner & Smith Incorporated (acting on behalf of the Liquidity Provider) purchases
any Applicable Unenhanced P-FLOATs and thereafter receives with respect to such purchased Applicable Unenhanced P-FLOATs, as the
holder of Liquidity Provider P-FLOATs or otherwise, either (A) proceeds from the liquidation of Unenhanced Bonds pursuant to the
terms of the related Trust Agreement in an amount less than the Purchase Price of such purchased Applicable Unenhanced P-FLOATs,
or (B) a distribution in kind of Unenhanced Bonds with a market value (based on a Quotation of Bond Price) less than such Purchase
Price, or (ii) to the extent that such amounts relate to the Applicable Freddie Mac Enhanced Bonds, either (A) Merrill Lynch Capital
Services, Inc. has paid or owes any money under the Reimbursement Agreement in connection with the Freddie Mac Liquidity Facility
for which its has not been reimbursed by the Pledgor or one of its affiliates, or (B) after the First Loss (as defined in the Reimbursement
Agreement) has been reduced to zero, Federal Home Loan Mortgage Corporation purchases any Applicable Enhanced P-FLOATs and thereafter
receives with respect to such purchased Applicable Enhanced P-FLOATs, as the holder of Liquidity Provider P-FLOATs or otherwise,
either (x) proceeds from the liquidation of Custodial Receipts, Series FM pursuant to the terms of the related Trust Agreement
in an amount less than the Purchase Price of such Applicable Enhanced P-FLOATs, or (y) a distribution in kind of Custodial Receipts,
Series FM with a market value (based on a Quotation of Bond Price) less than such Purchase Price, then, in any such case, the Pledgor
hereby agrees to pay such deficiency or amount paid or owing (a “Liquidity Provider Shortfall”) to the Pledgee
as provided herein.

 

    	7

    	 

    
 

(c)     The
Pledgor shall pay to the Pledgee or its affiliate (i) with respect to each Merrill Lynch Credit Enhancement, the credit enhancement
fee specified in each Notice of Deposit delivered pursuant to the Series Q Custody Agreement; (ii) with respect to the Freddie
Mac Credit Enhancement, the credit enhancement fee specified in the letter agreement entered into by the Pledgor and the Pledgee
on the date hereof; (iii) with respect to each Merrill Lynch Liquidity Facility, the liquidity fee specified in the related Trust
Agreement, to the extent not paid pursuant to the terms of such Trust Agreement; (iv) with respect to the Freddie Mac Liquidity
Facility, the liquidity fee specified in the letter agreement entered into by the Pledgor and the Pledgee on the date hereof; and
(v) with respect to each Trust Agreement, the remarketing fee specified in such Trust Agreement, to the extent not paid pursuant
to the terms of such Trust Agreement.

 

(d)     The
Pledgor’s obligation for any Credit Enhancer Shortfall pursuant to subsection (a) of this Section 2 or any Liquidity Provider
Shortfall pursuant to subsection (b) of this Section 2 (collectively, the “Shortfall Obligation”) and the Pledgor’s
obligation for credit enhancement fees, liquidity fees and remarketing fees pursuant to subsection (c) of this Section 2 (collectively,
the “Fee Obligation”), the obligation of the Pledgor under Section 11.03 of the Series FM Custody Agreement
(the “Put Obligation”), and any other obligation to the Pledgee hereunder, shall be a limited recourse obligation
of the Pledgor secured solely by the pledge of the Collateral. Notwithstanding the foregoing, to the extent that the Collateral
has been liquidated and any Shortfall Obligation or Fee Obligation has not been paid in full, such remaining Obligation shall be
a full recourse general obligation of the Pledgor, provided that (i) such full recourse general obligation shall not exceed $225,000,000,
and (ii) such full recourse general obligation shall be personal to the Pledgee and not assignable to any other Person. It is the
express interest of the parties hereto that all amounts paid or owed by Merrill Lynch Capital Services, Inc. under the Reimbursement
Agreement in connection with the Applicable Freddie Mac Enhanced Bonds and the Applicable Series FM Custodial Receipts shall be
deemed Shortfall Obligations under either subsection (a) or (b) of this Section 2. To the extent that any such amount is not clearly
a Credit Enhancer Shortfall or a Liquidity Provider Shortfall, the Pledgee shall be able to pick such designation in its sole discretion.
The Pledgor hereby acknowledges that, pursuant to Sections 10.01 and 10.03 of the Series FM Custody Agreement, following a Freddie
Mac Trigger Event (as defined in the Reimbursement Agreement), Freddie Mac shall be entitled to exercise any rights it may have
under the Series FM Custody Agreement with respect to the Collateral but only to the extent of the Boot Bonds and any amounts posted
hereunder as provided in Section 11.02 of the Series FM Custody Agreement.

 

(e)     The
Pledgee shall give the Pledgor prompt notice of each calculation of the Value Ratios, any Value Deficiencies and the market value
of the Additional Bonds pursuant to Section 4(f) and (g) of this Agreement.

 

    	8

    	 

    
 

3.     Further
Forbearance by Pledgee. The Pledgee hereby agrees that, notwithstanding the provisions of the Credit Enhancements to the contrary
and not withstanding the provisions of the Trust Agreements and the Liquidity Facilities to the contrary, so long as (i) the aggregate
market value (as determined by the Pledgee in its sole commercially reasonable discretion) of the Pledged Securities (other than
Pledged Securities delivered in connection with Section 11.04 of the Series FM Custody Agreement) shall be greater than the sum
of (A) the aggregate Value Deficiency with respect to the Enhanced Bonds, and (B) the aggregate Market Deficiency with respect
to the Applicable Unenhanced P-FLOATs, and (ii) no demand shall have been made on such Credit Enhancement pursuant to Section 4.01(c)
of the Series Q Custody Agreement or the Series FM Custody Agreement, as applicable, the Pledgee shall forbear from exercising
its right pursuant to Section 4.02(a)(v) of the Series Q Custody Agreement or Section 4.02(a)(vi) of the Series FM Custody Agreement,
as applicable, to cause the mandatory tender of one or more subseries of Applicable Custodial Receipts with respect to which the
Value Ratio shall be below the Minimum Value Ratio therefor and the Liquidity Provider shall forbear from exercising its right
under any Ratio Tender Event Clause to require a Mandatory P-FLOATs Tender Event with respect to any Applicable Unenhanced P-FLOATs
with respect to which the P-FLOATs Ratio shall be below the Minimum P-FLOATs Ratio. If upon any determination of the aggregate
Value Deficiency with respect to the Enhanced Bonds, the aggregate Market Deficiency with respect to the Applicable Unenhanced
P-FLOATs and the aggregate market value of the Pledged Securities (other than Pledged Securities delivered in connection with Section
11.04 of the Series FM Custody Agreement) shall be less than the sum of the aggregate Value Deficiency with respect to the Enhanced
Bonds and the aggregate Market Deficiency with respect to the Applicable Unenhanced P-FLOATs, the Pledgee shall continue to forbear
from exercising its right pursuant to Section 4.02(a)(v) of the Series Q Custody Agreement or Section 4.02(a)(vi) of the Series
FM Custody Agreement, as applicable, to cause the mandatory tender of one or more subseries of Applicable Custodial Receipts with
respect to which the Value Ratio shall be below the Minimum Value Ratio therefor and the Liquidity Provider shall continue to forbear
from exercising its right under any Ratio Tender Event Clause to require a Mandatory P-FLOATs Tender Event with respect to any
Applicable Unenhanced P-FLOATs with respect to which the P-FLOATs Ratio shall be below the Minimum P-FLOATs Ratio for a period
of fourteen (14) days.

 

4.     Delivery
and Valuation of Collateral.

 

(a)     Prior
to the execution and delivery of this Agreement, the Pledgor has delivered to the Collateral Agent the Additional Bonds identified
on Schedule 1 hereto and on Schedule 2 hereto. Any such Additional Bonds which are still held by the Collateral Agent on the date
hereof shall constitute Pledged Securities under this Agreement.

 

(b)     The
Pledgor may from time to time deliver additional Additional Bonds to the Collateral Agent. Each such delivery of additional Additional
Bonds shall be accompanied by a Notice of Delivery in the form attached hereto as Exhibit A. Upon each such delivery of additional
Additional Bonds to the Collateral Agent, such additional Additional Bonds shall become Pledged Securities under this Agreement.

 

(c)     With
the consent of the Pledgee, the Pledgor may from time to time deliver new Additional Bonds or other Pledged Securities to the Collateral
Agent in substitution for Pledged Securities then held by the Collateral Agent; provided that new Boot Bonds may be delivered to
the Collateral Agent in substitution for Boot Bonds then held by the Collateral Agent as provided and only as provided in the Series
FM Custody Agreement. Each such delivery of substitute Additional Bonds or other Pledged Securities shall be accompanied by a Notice
of Delivery in the form attached hereto as Exhibit A. Upon each such delivery of substitute Pledged Securities to the Collateral
Agent, (i) such substitute Pledged Securities shall become Pledged Securities under this Agreement, and (ii) the Pledged Securities
for which such Pledged Securities are substituted shall cease to be Pledged Securities under this Agreement and shall be released
to the Pledgor.

 

    	9

    	 

    
 

(d)     So
long as the aggregate market value of the Pledged Securities (as determined by the Pledgee in its sole commercially reasonable
discretion) continues to be greater than the sum of the aggregate Value Deficiency with respect to the Enhanced Bonds and the aggregate
Market Deficiency with respect to the Applicable Unenhanced P-FLOATs, the Pledgor may from time to time withdraw Additional Bonds
or other Pledged Securities held by the Collateral Agent; provided that Boot Bonds may be withdrawn as provided and only as provided
in the Series FM Custody Agreement. Upon each such withdrawal of Pledged Securities from the Collateral Agent, such Pledged Securities
shall cease to be Pledged Securities under this Agreement and shall be released to the Pledgor.

 

(e)     The
Collateral Agent shall hold all of the Pledged Securities delivered to it pursuant to this Agreement in custody only, identified
separate and apart from the general assets of the Collateral Agent in an account designated and maintained in the name of the Pledgee.
The Collateral Agent shall not have any authority to assign, transfer, pledge, setoff or otherwise dispose of any of the Pledged
Securities, or of any interests therein, except as provided hereunder or as required by law.

 

(f)     By
the close of business on Wednesday of each week, the Pledgee shall determine the Value Ratio and any Value Deficiency with respect
to the Bonds and notify the Custodian thereof by facsimile or other electronic means. Promptly upon receipt of such notice, the
Custodian shall notify the Holders of the Custodial Receipts of such Value Ratio by facsimile or other electronic means.

 

(g)     If
any Value Deficiency is determined by the Pledgee pursuant to subsection (f) of this Section 4 and either the Pledgor or any Holder
of related Custodial Receipts notifies the Pledgee that the Pledgor or such Holder, as applicable, disputes such determination
of the related Value Ratio by the Pledgee, the Pledgee shall redetermine such Value Ratio based on the arithmetic average of at
least three bids solicited from broker-dealers located in New York City selected by the Pledgee in its absolute discretion. The
Pledgee shall provide the Custodian with copies of all such bids and the Custodian shall transmit such copies to the Holders of
the Custodial Receipts.

 

5.     Grant
of Security Interest.

 

(a)     The
Pledgor hereby grants to the Pledgee a continuing first and prior security interest in, and general first lien on, the Collateral
to secure the payment of the Obligations. As long as (i) any Applicable Custodial Receipts shall be outstanding with respect to
which a Credit Enhancement has been delivered, (ii) any Applicable P-FLOATs shall be outstanding with respect to which the Pledgee
shall have delivered a Liquidity Facility, or (iii) any Obligations shall be due and unpaid, the security interest in, and lien
on, the Collateral pursuant hereto shall continue in full force and effect.

 

    	10

    	 

    
 

(b)     The
security interests granted pursuant to this Section 4 (and the rights and powers granted to the Pledgee hereunder with respect
thereto or to the Collateral) are granted as security only, and shall not subject the Pledgee to, or transfer or in any way affect
or modify, any obligation or liability of the Pledgor under or related in any way to any of the Collateral or any transaction which
gave rise thereto.

 

6.     Further
Assurances. The Pledgor agrees that at any time and from time to time, at the expense of the Pledgor, the Pledgor will promptly
execute and deliver all further instruments and documents and take all further action that may be necessary or desirable, or that
the Pledgee may reasonably request, to preserve, perfect and protect any security interest granted or purported to be granted hereby
or to enable the Pledgee to exercise and enforce its rights and remedies hereunder with respect to any Collateral. Without limiting
the generality of the foregoing, it will execute and file such financing statements (including without limitation amendments thereto
and continuation statements thereof), assignments, short-form security agreements and other documents and instruments, and do all
such other acts, relating to the Collateral and the Pledgee’s interests therein as the Pledgee may reasonably request; and
will not file or permit to be filed any financing statement (or amendment thereto or continuation statement thereof) with respect
to any of the Collateral not naming the Pledgee as the only secured party. The Pledgor hereby authorizes the Pledgee, at the Pledgor’s
expense, to file financing statements (including without limitation amendments thereto and continuation statements thereof) or
such other documents as described above without the Pledgor’s signature to perfect the security interest of the Pledgee in
any jurisdiction in which such filing may be necessary or as the Pledgee may reasonably request and, to the extent lawful, appoints
the Pledgee as its attorney-in-fact (without requiring the Pledgee to act as such) to execute any financing statements (including
without limitation any amendments thereto or continuation statements thereof or such other documents as described above).

 

7.     Representations
and Warranties. The Pledgor represents and warrants to the Pledgee, and shall be deemed continuously to represent and warrant
to the Pledgee, that:

 

(a)     The
Pledgor has good and marketable title to, and is the owner of, the Collateral, free and clear of all Liens, adverse claims and
transfer restrictions, except Liens arising pursuant hereto, Liens created under the Series FM Custody Agreement and routine transfer
restrictions for the purpose of complying with the securities laws, and no financing statement or other instrument with respect
to any of the Collateral has been recorded, registered or filed otherwise than with respect to the Lien arising pursuant hereto.

 

(b)     To
the Pledgor’s best knowledge, the Pledgee has a valid, first and prior perfected security interest in, and a general first
lien upon, the Collateral, in each case free and clear of all Liens (senior, pari passu or junior), except as provided for
under the Series FM Custody Agreement.

 

(c)     The
Collateral may be properly pledged hereunder.

 

(d)     To
the Pledgor’s best knowledge, no claim to any of the Collateral, or defense, claim, set-off or counterclaim of any obligor
on or with respect to any of the Collateral exists which could be asserted against the Pledgee, whether in any proceeding to enforce
the Collateral or otherwise.

 

    	11

    	 

    
 

(e)     Each
of the Pledged Securities has been (or, in the case of Pledged Securities delivered after execution hereof, shall as of the date
of delivery to the Pledgee hereunder and at all times thereafter be) duly and validly issued and fully paid and non-assessable.

 

8.     Covenants
and Agreements. The Pledgor hereby covenants and agrees that, for the term of this Agreement:

 

(a)     It
will defend its title to, and the Pledgee’s first and prior Lien upon, the Collateral against all claims of all Persons whomsoever,
except for Liens created under the Series FM Custody Agreement.

 

(b)     It
will keep the Collateral free from all Liens, other than the Lien created pursuant to Section 4 hereof and except for Liens created
under the Series FM Custody Agreement, and will pay or cause to be paid promptly when due all taxes, fees, assessments and other
charges now or hereafter imposed upon any of the Collateral.

 

(c)     Except
as explicitly provided for herein and in the Series FM Custody Agreement, it will not, without the prior written consent of the
Pledgee, sell, assign, pledge, exchange or dispose of any of the Collateral in any manner whatsoever or attempt to do any of the
foregoing or agree to any modification or cancellation of, or substitution for, any of the Collateral. In the event of any disposition
of any of the Collateral, the Proceeds will remain Collateral hereunder. The receipt by the Pledgee of all or any part of the Proceeds
of any sale, assignment, pledge, exchange or disposition of any of the Collateral shall not be deemed or construed to be a consent
to any such sale, assignment, pledge, exchange or other disposition.

 

(d)     It
will cause all Pledged Securities to be delivered to the Collateral Agent, as custodial agent for the Pledgee, either registered
in the name of the Pledgee or indorsed to the Pledgee (or registered in the name of the Collateral Agent or its nominee on behalf
of the Pledgee or indorsed to the Collateral Agent or its nominee on behalf of the Pledgee) by an effective instrument by duly
authorized officers of the Pledgor, with the signature or signatures guaranteed. Notwithstanding the foregoing, the Boot Bonds,
to the extent deposited under the Series FM Custody Agreement, shall be registered in the name of the Custodian thereunder.

 

(e)     If
it shall become entitled to receive or shall receive any security, option or right, whether as an addition to, or in substitution
for, or in exchange for, any of the Pledged Securities or otherwise, the Pledgor shall accept any such certificates, instruments,
options or rights as trustee for the Pledgee, and shall forthwith deliver the same in the exact form received accompanied by whatever
duly-executed documents as shall be necessary to enable the Pledgee to perfect its security interest therein.

 

(f)     Subject
to Section 2(d) hereof, the Pledgor hereby agrees to indemnify and hold the Pledgee harmless from and against any and all loss,
liability or expense (“Loss”) which the Pledgee may sustain or incur, or which may be claimed against it, and
which arises out of or relates to this Agreement, the Series FM Custody Agreement (to the extent related to the Applicable Series
FM Custodial Receipts or the Applicable Enhanced P-FLOATs) or the Reimbursement Agreement (to the extent related to the Applicable
Series FM Custodial Receipts or the Applicable Enhanced P-FLOATs), or the Pledgee’s duties and obligations hereunder or thereunder,
except for any such Loss resulting from the gross negligence or willful misconduct of the Pledgee.

 

    	12

    	 

    
 

9.     Release
of Collateral. Upon the termination of all Credit Enhancements related to Applicable Custodial Receipts and Liquidity Facilities
related to Applicable P-FLOATs and the payment of any and all related Obligations, the Pledgee shall promptly give the Collateral
Agent written notice to release the remaining Pledged Securities to the Pledgor. Upon such release of Pledged Securities to the
Pledgor, such Pledged Securities shall cease to be Collateral under this Agreement.

 

10.     Rights
and Remedies upon Event of Default.

 

(a)     Upon
the occurrence and during the continuance of an Event of Default as specified in clause (i) of the definition thereof in Section
1(b) hereof, the Pledgee shall have the rights and remedies provided in Section 11(a) hereof.

 

(b)     Upon
the occurrence and during the continuance of any other Event of Default (in addition to any remedy provided to a secured creditor
upon default under Articles 8 or 9 of the New York Uniform Commercial Code):

 

(i)     The
Pledgee shall have the right to receive, endorse, assign or deliver in its own name or the name of the Pledgor any and all checks,
drafts and other instruments for the payment of money relating to or constituting part of the Collateral and the Pledgor hereby
waives notice of presentment, protest and nonpayment of any instrument so endorsed. In furtherance of the foregoing, the Pledgor
hereby irrevocably appoints the Pledgee, or any of its officers or designees, the Pledgor’s lawful attorney-in-fact (without
requiring any of them so to act), with power of substitution, in the name of the Pledgor (i) to endorse the name of the Pledgor
upon any of the Collateral, including Proceeds; (ii) to demand, collect, receive payment of, receipt for and give discharges and
releases of any of the Collateral; (iii) to commence and prosecute any and all suits, actions or proceedings at law or in equity
in any court of competent jurisdiction to collect or otherwise realize on any of the Collateral or to enforce any rights in respect
thereof; (iv) to initiate, settle, compromise, compound, adjust or defend any actions, suits or proceedings relating to or pertaining
to any of the Collateral; and (v) to sell, transfer, assign, discount, negotiate or otherwise deal in (in a commercially reasonable
manner) all or any portion of the Collateral or Proceeds and generally to perform all other acts necessary or desirable to realize
on, and obtain the benefits of, the Collateral and otherwise to carry out the intention of this Agreement, as fully and effectively
as though the Pledgee were the absolute owner thereof, and the Pledgor hereby ratifies and confirms all that the Pledgee shall
do by virtue of this appointment. In any action hereunder, the Pledgee shall be entitled to the appointment of a receiver to take
possession of all or any portion of the Collateral. The Pledgee shall not be responsible or liable for any loss or destruction
of all or any part of the Collateral unless the same shall happen through gross negligence or willful misconduct of the Pledgee.
The Pledgee shall not, under any circumstances, absent its gross negligence or willful misconduct, have any liability for any error
or omission made in the settlement, collection or payment or other disposition of any or all of the Collateral or of any instrument
received in payment therefor. The costs of collection, sale or other disposition, notification and enforcement, including but not
limited to reasonable counsel fees and disbursements, shall be borne solely, or reimbursed to the Pledgee by, the Pledgor.

 

    	13

    	 

    
 

(ii)     The
Pledgee, with or without taking possession, may sell or cause to be sold, in one or more sales (which shall be conducted in a commercially
reasonable manner in accordance with law), at such price as the Pledgee may deem adequate, and for cash or on credit or for future
delivery, with or without assumption of any credit risk, all or any portion of the Collateral, at a public or private sale, without
demand of performance or notice or intention to sell or of time or place of sale, and the Pledgee may be the purchaser of all or
any portion of the Collateral so sold. The purchaser(s) at any such sale shall thereafter hold the same absolutely, free from any
claim or right of whatever kind, including any equity of redemption, of the Pledgor, any such demand, notice, claim, right or equity
being hereby expressly waived and released. The Pledgee shall under no circumstances incur any liability as a result of the sale
of the Collateral or any part thereof, at any sale conducted in accordance with the foregoing. The Pledgor hereby waives any claims
against the Pledgee arising by reason of the fact that the price at which the Collateral may have been sold at any commercially
reasonable private sale was less than the price which might have been obtained at a public sale or was less than the then total
unpaid Obligations.

 

(iii)     The
Pledgor recognizes that the Pledgee may not deem it desirable to effect a public sale of any or all of the Pledged Securities by
reason of certain prohibitions contained in the Securities Act of 1933, as amended (the “Securities Act”), and
applicable state securities laws or otherwise, but may deem it desirable to resort to one or more private sales thereof to a restricted
group of purchasers which will be obliged to agree, among other things, to acquire such Securities for their own account for investment
and not with a view to the distribution or resale thereof. The Pledgor acknowledges and agrees that any such private sale may result
in prices and other terms less favorable to the seller than if such sale were a public sale, and, notwithstanding such circumstances,
agrees that any such private sale shall be deemed to have been made in a commercially reasonable manner. The Pledgee shall be under
no obligation to delay a sale of any of the Pledged Securities for the period of time necessary to permit the Pledgor to register
such Pledged Securities for public sale under the Securities Act, or under applicable state securities laws, even if the Pledgor
would agree to do so.

 

11.     Application
of Proceeds.

 

(a)     If
an Event of Default as specified in clause (i) of the definition thereof in Section 1(b) hereof shall have occurred, the Collateral
Agent shall, at the direction of the Pledgee, sell one or more of the Additional Bonds at the highest obtainable price under current
market conditions and/or sell, otherwise dispose of or otherwise realize on the other Collateral as needed. All proceeds received
from the sale or other disposition of, or realization on or with respect to, all or any part of the Collateral shall be applied
by the Pledgee:

 

    	14

    	 

    
 

First,
to the Credit Enhancer or Merrill Lynch & Co., Inc., as the case may be, in an amount equal to all amounts owed to the Credit
Enhancer or Merrill Lynch & Co., Inc., as applicable, in connection with demands on any Merrill Lynch Credit Enhancement pursuant
to Section 4.01(b) and (c) and, in connection with a Mandatory Tender Event specified in Section 4.02(a)(v) of the Series Q Custody
Agreement, Section 4.02(e) of the Series Q Custody Agreement;

 

Second,
to Merrill Lynch Capital Services, Inc. or Merrill Lynch & Co., Inc., as the case may be, in an amount equal to all amounts
owed to Federal Home Loan Mortgage Corporation in connection with the Reimbursement Agreement with respect to the Applicable Series
FM Custodial Receipts;

 

Third,
to the investment in Eligible Investments selected by the Pledgee to be held by the Collateral Agent as Additional Bonds, in an
amount sufficient to cause the aggregate market value of the Additional Bonds held by the Collateral Agent to be greater than the
sum of the aggregate Value Deficiency with respect to the Enhanced Bonds and the aggregate Market Deficiency with respect to the
Applicable Unenhanced P-FLOATs on the date of such sale; and

 

Fourth,
to the Pledgor, the balance remaining.

 

The rights granted to the Pledgee pursuant
to this Section 11(a) shall be in addition to the rights of the Credit Enhancer pursuant to Section 4.02 of the Custody Agreement.

 

(b)     If
any other Event of Default shall have occurred and be continuing, all proceeds received from the sale or other disposition of,
or realization on or with respect to, all or any part of the Collateral shall be applied by the Pledgee as follows:

 

First,
to the payment of the costs and reasonable expenses of the Pledgee in the administration of this Agreement and in any sale, disposition
or realization hereunder, including without limitation reasonable fees and disbursements of counsel for the Pledgee and all reasonable
expenses, liabilities and advances made or incurred by the Pledgee in connection therewith;

 

Second,
to the payment of Obligations (in such order as the Pledgee shall determine in its sole discretion); and

 

Third,
after all outstanding Obligations have been paid and satisfied in full, to the Pledgor or to whomsoever shall be lawfully entitled
to receive the same or as a court of competent jurisdiction shall determine; provided that no amounts shall be released to the
Pledgor to the extent doing so would (i) cause the aggregate market value of the Collateral hereunder to be less than the sum of
the aggregate Value Deficiency with respect to the Enhanced Bonds and the aggregate Market Deficiency with respect to the Applicable
Unenhanced P-FLOATs, (ii) would cause the Pledgor to be in default on any Obligations owed to the Pledgee, or (iii) any amounts
are required to be posted hereunder as provided in Sections 11.02 and 11.04 of the Series FM Custody Agreement.

 

    	15

    	 

    
 

12.     Distributions
on Pledged Securities.

 

(a)     Unless
an Event of Default shall have occurred and be continuing, all cash distributions on the Pledged Securities (other than the Boot
Bonds) shall be paid to the Pledgor. Payments on the Additional Bonds (other than the Boot Bonds) received by the Collateral Agent
shall be paid to the Pledgor. All cash distributions and payments on the Boot Bonds shall be made as provided in the Series FM
Custody Agreement.

 

(b)     
The Collateral Agent shall arrange with the trustee or paying agent for each issue of Additional Bonds to have payments on such
Additional Bonds made by wire transfer to the Collateral Agent in accordance with the terms thereof. The Collateral Agent shall
make the payments to the Pledgor pursuant to this Section 12(a) in immediately available funds on the same day that the Collateral
Agent receives such amounts in immediately available funds.

 

(c)     If
an Event of Default shall have occurred and be continuing, all cash distributions on the Pledged Securities shall immediately be
paid to or retained by the Collateral Agent as additional Collateral hereunder.

 

13.     Right
to Take Action as Holder of Pledged Securities.

 

(a)     With
respect to any consents, ratifications and waivers with respect to the Pledged Securities and any other actions with respect to
the Pledged Securities permitted by the provisions of the indenture therefor which would be financially adverse to the Pledgee
in any respect, the Pledgor hereby assigns to the Pledgee the sole right, from time to time, to give such consents, ratifications
and waivers and to take such other actions with respect to the Pledged Securities; and the Pledgor shall, upon receiving a written
request from the Pledgee, deliver to the Pledgee or as specified in such request such proxies, powers of attorney, consents, ratifications
and waivers in respect of any Pledged Securities which are registered in the Pledgor’s name or in the name of its nominee,
as shall be specified in the Pledgee’s request and as shall be satisfactory to the Pledgee in form and substance.

 

(b)     So
long as no Event of Default shall have occurred and be continuing, the Pledgor shall retain the right, upon giving notice thereof
to the Pledgee, to give any other consents, ratifications and waivers with respect to the Pledged Securities and to take any other
actions with respect to the Pledged Securities permitted by the provisions of the indenture therefor.

 

(c)     If
an Event of Default shall have occurred and be continuing, the Pledgee shall have the right to the extent permitted by law, and
the Pledgor shall take all such action as may be necessary or appropriate to give effect to such right, to cause the Pledged Securities
to be registered in its name.

 

14.     Action
by Collateral Agent. Any right or remedy granted the Pledgee hereunder may (at the Pledgee’s direction) be exercised
on the Pledgee’s behalf by the Collateral Agent as fully as if such right were exercised by the Pledgee directly.

 

15.     Security
Interest Absolute. All rights of the Pledgee and all pledges made, and liens and security interests granted, hereunder shall
be absolute and unconditional and irrevocable, under any and all circumstances and conditions of any kind or description, including
any which would otherwise constitute a defense or discharge of a guarantor or pledgor.

 

    	16

    	 

    
 

16.     Remedies
Cumulative, Etc. The rights, remedies and benefits of the Pledgee herein specified are cumulative and not exclusive of any
other rights, remedies or benefits which the Pledgee may have hereunder or at law, in equity, by statute or otherwise. Without
limiting the generality of the foregoing, the Pledgee shall have all rights and remedies of a secured party under Article 9 of
the Uniform Commercial Code as adopted in the State of New York. Each Pledgor hereby expressly agrees that the Pledgee shall not
be required to exercise any particular of the rights, powers, remedies or benefits hereunder or to realize or attempt to realize
on any security for any or all of the Obligations. Without limiting the generality of the foregoing, upon the occurrence and during
the continuance of an Event of Default, the Pledgee shall (i) be entitled to seek to realize upon or enforce the Collateral in
such order and at such times as it may from time to time reasonably determine, (ii) not be required to exhaust or enforce any particular
portion of the Collateral before seeking to realize or enforce upon any other portion thereof, and (iii) not be required to foreclose
or realize on the Collateral, but may continue to hold, and collect and apply all sums paid thereon to the payment of the Obligations.

 

17.     Expenses.
The Pledgor will pay to the Pledgee all reasonable expenses (including reasonable fees and expenses of special counsel to the Pledgee)
of, or incident to, any amendment, waiver or supplement to this Agreement and the administration hereof and all such expenses of,
or incident to, any actual or attempted sale or other disposition of, or any exchange, enforcement, collection, compromise or settlement
of or with respect to, all or any of the Collateral, by litigation or otherwise; and the Pledgor agrees that all such expenses
shall constitute additional obligations secured by the Collateral and that the Pledgee may at any time apply to the payment of
such expenses all moneys received by it pursuant hereto.

 

18.     Delay
Not a Waiver, Etc. No delay on the part of the Pledgee in exercising any power or right hereunder shall operate as a waiver
thereof nor shall any single or partial exercise of any power or right hereunder preclude any other or further exercise thereof
or the exercise of any other power or right. The Pledgor hereby waives presentment, notice of dishonor and protest of all instruments
included in or evidencing liability of the Pledgor in respect of the Collateral and any and all other notices and demands whatsoever
(except notices specifically provided for herein) whether or not relating to such instruments.

 

    	17

    	 

    
 

19.     Guaranty.

 

(a)     The
Guarantor hereby absolutely, unconditionally and irrevocably guarantees (as primary obligor and not as surety merely) the due and
punctual payment and performance, when and as the same shall become due, of each and every Guaranteed Obligation, at the time and
place and otherwise in accordance with the terms of this Agreement, irrespective of (i) the validity, binding effect, legality,
enforceability or amendment of, or waiver of compliance with, this Agreement with respect to the Guarantor or the Pledgor, (ii)
whether this Agreement shall have been duly executed by the Guarantor and the Pledgor, (iii) any change in the existence or structure
of, or the bankruptcy or insolvency of, the Collateral Agent, the Guarantor or any other Person, (iv) the lack of perfection of
any Lien in (or the release in whole or in part of) any collateral at any time, directly or indirectly, securing any of the Guaranteed
Obligations, (v) the absence of any action to enforce this Agreement or any collateral at any time securing any of the Guaranteed
Obligations (or to enforce any right against any other Person who may be obligated in respect of any amount included within the
Guaranteed Obligations), (vi) any extension, renewal, settlement, compromise, waiver or release in respect of any obligation of
any party to the this Agreement or of the Guarantor hereunder or of any other Person, (vii) the existence of any claim, set-off,
counterclaim or other right that any Person other than the Guarantor may have against the Pledgee or any other Person, or (viii)
any other circumstance whatsoever that might otherwise constitute a legal or equitable discharge of a guarantor. The Guarantor
hereby agrees that, upon default in the payment and performance when and as due of any Guaranteed Obligation, the Guarantor will
forthwith cause each and every such Guaranteed Obligation to be punctually paid and performed, when and as the same shall become
due, and as if such payment or performance were made by the Pledgor. The Guarantor hereby expressly waives diligence, presentment,
demand, protest or notice of any kind whatsoever, as well as any requirement that the Pledgee or any other Person file claims in
the event of receivership or bankruptcy of the Guarantor, the Collateral Agent or any other Person or exhaust any right or take
any action against the Guarantor, the Collateral Agent or any other Person or any collateral at any time securing any of the Guaranteed
Obligations and hereby consents to any and all extensions of time of payment or performance of any or all of the Guaranteed Obligations.
This guaranty is a guaranty of payment and not of collection merely and shall be a continuing guaranty and, as such, shall remain
operative and in full force and effect until all Guaranteed Obligations shall have been paid and actually received in full by the
Pledgee. If at any time payment of any Guaranteed Obligation is rescinded or must otherwise be restored or returned upon (or as
a result of) the insolvency, bankruptcy or reorganization of the Guarantor, the Collateral Agent or any other Person, or otherwise,
the Guarantor’s obligations hereunder with respect to such Guaranteed Obligation shall be reinstated at such time as though
such payment had not been made; and the Guarantor agrees that it will indemnify the Pledgee on demand for all costs and expenses
(including without limitations reasonable fees and disbursements of counsel) incurred by the Pledgee in connection with such reinstatement.

 

(b)     The
Guarantor hereby irrevocably agrees that it will not exercise any and all rights of subrogation, indemnification, reimbursement
and similar rights which the Guarantor may have at any time relating to the Guaranteed Obligations, including, without limitation,
all rights that would result in the Guarantor’s being deemed a creditor of the Collateral Agent under the United States Bankruptcy
Code, Title 11 of the United States Code, as amended (the “Bankruptcy Code”), until such time as the Guaranteed
Obligations have been paid and satisfied in full.

 

(c)     The
Guarantor agrees that for purposes of Section 19(a) hereof, as between the Guarantor and the Pledgee all or any part of the Guaranteed
Obligations (as determined in the sole discretion of the Pledgee) which would become due but for the operation of any stay under
Section 362(a) of the Bankruptcy Code, or the operation of Section 502(b) of the Bankruptcy Code, may be treated as having become
forthwith due and payable for purposes hereof and that, in the event of such determination such Guaranteed Obligations shall be
treated as having become forthwith due and payable for purposes of this Section 19.

 

    	18

    	 

    
 

(d)     The
Guarantor’s guaranty obligation to the Pledgee pursuant to this Section 19 shall be a general obligation of the Guarantor.

 

20.     Collateral
Agent’s Standard of Care, Liabilities and Indemnity.

 

(a)     The
Collateral Agent shall exercise reasonable care in its custody, preservation and disposal of the Collateral and shall be deemed
to have exercised reasonable care if it exercises at least the same degree of care as it would exercise with respect to a like
transaction in which it alone is interested.

 

(b)     The
Collateral Agent shall not be liable to the Pledgor or the Pledgee for any action taken or omitted by it hereunder at the direction
of the Pledgee or the Pledgor. The Collateral Agent shall be liable only for its gross negligence, bad faith or willful misconduct.

 

(c)     The
Pledgee hereby agrees to indemnify the Collateral Agent and hold it harmless against any and all claims, losses, liabilities, damages
or expenses, including reasonable counsel fees, howsoever arising from or in connection with this Agreement or the performance
of its duties hereunder, provided that nothing contained herein shall require that the Collateral Agent be indemnified for negligence,
bad faith or willful misconduct.

 

(d)     The
provisions of Articles V and VII of the Series Q Custody Agreement pertaining to the performance by the Custodian of its duties
thereunder and the provisions of Article XIII of the Trust Agreements pertaining to the performance by the Trustee of its duties
thereunder shall be applicable, as appropriate, to the performance by the Collateral Agent of its duties under this Agreement.

 

21.     Successor
Collateral Agent

 

(a)     If
at any time the Collateral Agent becomes incapable of acting or is adjudged a bankrupt or insolvent, or a receiver of the Collateral
Agent or of its property is appointed, or any public officer takes charge or control of the Collateral Agent or of its property
or affairs for the purpose of rehabilitation, conservation or liquidation, then the Pledgee or the Pledgor may petition any court
of competent jurisdiction for the removal of the Collateral Agent and the appointment of a successor Collateral Agent.

 

(b)     If
at any time the Collateral Agent notifies the Pledgee and the Pledgor that it elects to resign as Collateral Agent, the Pledgee
shall, within 45 days after the delivery of the notice of resignation (and also within 45 days of a notice or removal pursuant
to subsection (a) of this Section 21), appoint a successor Collateral Agent, which is to be a commercial bank or trust company
having its principal office in the United States of America and having a combined capital and surplus of at least $50,000,000 or
whose obligations hereunder are guaranteed by a Person whose capital and surplus or net worth is at least that amount. If no successor
Collateral Agent has been so appointed within such 45-day period, the Collateral Agent may petition any court of competent jurisdiction
for the appointment of a successor Collateral Agent. Any corporation or association into or with which the Collateral Agent may
be merged, consolidated or converted will be the successor of the Collateral Agent without the execution or filing of any document
or any further act.

 

    	19

    	 

    
 

(c)     Notwithstanding
the foregoing, no resignation or removal of the Collateral Agent in accordance with the provisions hereof shall become effective
until a successor Collateral Agent has accepted its appointment hereunder.

 

(d)     Any
corporation into which the Collateral Agent maybe merged or converted or with which it may be consolidated or any corporation succeeding
to all or substantially all the business of the department or group which administers this Agreement shall be the successor of
the Collateral Agent hereunder provided that such corporation shall be otherwise eligible under this Section 21, without the execution
or filing of any paper or any further act on the part of any of the parties hereto.

 

22.     Amendment
or Modification.

 

(a)     No
amendment of this Agreement shall be effective unless in writing and signed by an authorized officer of each of the parties hereto.
No modification or waiver of, nor consent to departure by any Pledgor from, the terms of this Agreement shall be effective unless
the same shall be in writing and signed by the Pledgee.

 

(b)     Notwithstanding
the foregoing, the Pledgee and the Pledgor may from time to time deliver to the Collateral Agent revised Schedules 1 and 2 hereto
reflecting the current Additional Bonds as of the date of such revised Schedule.

 

(c)     To
the extent that any obligations of the Pledgor under this Agreement shall be modified by reason of the amendment or modification
of the Series FM Custody Agreement, the Reimbursement Agreement or any other document related to the foregoing, such modification
of such obligations of the Pledgor shall not be effective unless such amendment or modification of the Series FM Custody Agreement,
the Reimbursement Agreement or such other related document shall have been consented to in writing by the Pledgor, which consent
shall not be unreasonably withheld, it being understood that any increase in the amount of any obligations or the likelihood of
any additional obligation arising shall be a reasonable basis for withholding such consent.

 

23.     Notices.
Any notice authorized or required by this Agreement shall be sufficiently given if in writing and addressed to the receiving party
and hand delivered or sent by telecopy or other facsimile machine to the individuals at the address specified below or to such
other person or persons as the receiving party may from time to time designate to the other parties in writing. Such notice shall
be effective upon receipt but, in the event that notice is sent by telecopy or some other form of facsimile transmission, receipt
will be considered to have occurred only after the sending party has verified receipt by telephoning the number herein provided
for calls for confirmation.

 

(i) To the Pledgor:

 

MuniMae TE Bond Subsidiary, LLC

621 East Pratt Street

Suite 300

Baltimore, Maryland 21202

Attention: Bond Asset Management

Facsimile No.: (410) 727-5387

Telephone No.: (443) 263-2900

 

    	20

    	 

    
 

with a copy to:

 

			Stephen A. Goldberg

Gallagher Evelius & Jones LLP

218 North Charles Street

Suite 400

Baltimore, Maryland 21201

 

(ii) To the Pledgee:

 

Merrill Lynch Capital Services, Inc.

Four World Financial Center

North Tower, Ninth Floor

250 Vesey Street

New York, New York 10080

Attention: Edward J. Sisk

Facsimile No.: (212) 449-9856

Telephone No.: (212) 449-9938

 

(iii) To the Guarantor:

 

Municipal Mortgage & Equity, LLC

621 East Pratt Street

Suite 300

Baltimore, Maryland 21202

Attention:
Bond Asset Management

Facsimile No.: (410) 727-5387

Telephone No.: (443) 263-2900

 

with a copy to:

 

			Stephen A. Goldberg

Gallagher Evelius & Jones LLP

218 North Charles Street

Suite 400

Baltimore, Maryland 21201

 

(iv) To the Collateral
Agent:

 

U.S. Bank Trust National Association

100 Wall Street

Suite 1600

New York, New York 10005

Attention: Corporate Trust Services

Facsimile No.: (212) 612-3203

Telephone No.: (212) 612-3445

 

    	21

    	 

    
 

24.     Governing
Law; Consent to Jurisdiction; Waiver of Jury Trial. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH
THE LAWS OF THE STATE OF NEW YORK WITHOUT GIVING EFFECT TO PRINCIPLES OF CONFLICT OF LAWS. THE PLEDGOR HEREBY IRREVOCABLY CONSENTS
TO THE NON-EXCLUSIVE JURISDICTION OF ANY NEW YORK STATE OR FEDERAL COURT SITTING IN THE BOROUGH OF MANHATTAN, THE CITY OF NEW YORK,
OVER ANY SUIT, ACTION OR PROCEEDING ARISING OUT OF, OR RELATING TO, THIS AGREEMENT AND HEREBY IRREVOCABLY WAIVES ANY OBJECTION
TO THE VENUE OF ANY SUCH COURT AS WELL AS ANY OBJECTION WITH RESPECT THERETO OF INCONVENIENT FORUM. THE PLEDGOR AND THE PLEDGEE
EACH HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT IT CAN EFFECTIVELY DO SO UNDER APPLICABLE LAW, ALL RIGHT TO TRIAL BY JURY
IN ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT.

 

25.     Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors
and assigns (including, with respect to any assignee of the Pledgee, whether or not an express assignment of rights hereunder is
made). The Pledgor may not assign any of its rights or obligations hereunder without the prior written consent of the Pledgee,
which consent shall not be unreasonably withheld.

 

26.     Entire
Agreement; Severability. This Agreement constitutes the entire agreement and understanding of the parties with respect to the
subject matter hereof and supersedes all oral agreements and prior writings with regard thereto, including the Predecessor Pledge
and Security Agreement which is hereby terminated. In case one or more of the provisions contained in this Agreement shall be or
shall be deemed to be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining
provisions contained herein shall not in any way be affected or impaired thereby. If any provision of this Agreement shall be or
shall be deemed to be illegal, invalid or unenforceable under the applicable laws and regulations of one jurisdiction, such provision
shall not thereby be rendered illegal, invalid or unenforceable in any other jurisdiction.

 

27.     Counterparts.
This Agreement may be executed in any number of counterparts, with the same effect as if the signatures thereto and hereto were
upon the same instrument.

 

28.     Headings.
The headings of the Sections of this Agreement are inserted for convenience only and do not form part of this Agreement.

 

    	22

    	 

    
 

IN WITNESS WHEREOF,
the parties hereto have caused this Second Amended and Restated Pledge and Security Agreement to be duly executed, all as of the
day and year first above written.

 

	 	MUNIMAE TE BOND SUBSIDIARY, LLC,	 
	 	 	as Pledgor	 
	 	 	 	 
	 	By:	/s/ Gary Mentesana	 
	 	 	Name:	 
	 	 	Title:	 
	 	 	 	 
	 	MERRILL LYNCH CAPITAL SERVICES, INC.,	 
	 	 	as Pledgee	 
	 	 	 	 
	 	By:	/s/ James Nacos	 
	 	 	Name:	 
	 	 	Title:	 
	 	 	 	 
	 	MUNICIPAL MORTGAGE & EQUITY, LLC,	 
	 	 	as Guarantor	 
	 	 	 	 
	 	By:	/s/ Gary Mentesana 	 
	 	 	Name:	 
	 	 	Title:	 
	 	 	 	 
	 	U.S. BANK TRUST NATIONAL ASSOCIATION,	 
	 	 	as Collateral Agent	 
	 	 	 	 
	 	By:	/s/ Charles P. Sheridan	 
	 	 	Name:	 
	 	 	Title:	 

 

    	23

    	 

    
 

Exhibit A

 

FORM
OF NOTICE OF DELIVERY

 

U.S. Bank Trust National Association,

as Collateral Agent

100 Wall Street, Suite 1600

New York, New York 10005

Attention: Corporate Trust Services

 

Ladies and Gentlemen:

 

Pursuant to Section
[4(b)][4(c)] of the Second Amended and Restated Pledge and Security Agreement, dated as of February __, 2009 (the “Agreement”),
among MuniMae TE Bond Subsidiary, LLC, Merrill Lynch Capital Services, Inc., Municipal Mortgage & Equity, LLC and U.S. Bank
Trust National Association, as Collateral Agent, the Pledgor hereby delivers the following [additional] [substitute] Additional
Bonds:

 

Issuer:

 

Bonds:

 

Principal Amount:

 

 

Capitalized terms used
in this Notice of Delivery shall have the meanings given them in the Agreement.

 

Dated: ________ __,
20__.

 

	 	MUNIMAE TE BOND SUBSIDIARY, LLC,
	 	as Pledgor
	 	 
	 	By:	 
	 	 	Authorized Signatory

 

    	A-1

    	 

    
 

Acknowledged:

 

	U.S. BANK TRUST  NATIONAL ASSOCIATION,	 
	as Collateral Agent	 
	 	 
	By:	 	 
	 	Authorized Signatory	 

 

    	A-2

    	 

    
 

Schedule 1

 

Additional Bonds

 

	Name	Issuer and Bonds	Principal
 Amount	CUSIP No.
	Barkley Place	Housing Finance Authority of Lee County, Florida Multi-Family Mortgage Revenue Refunding Bond (Barkley Place Project) Series B 1995	$3,480,000	52349HAD5
	Bedford Park	$9,325,000 City of Indianapolis, Indiana Multifamily Housing Revenue Bonds (Bedford Park Apartments Project) Series 2000	$9,274,095	455284BU2
	Columbia Knoll	Subordinate Custody Receipt for payments of principal, premium, if any, and interest with respect to $24,500,000 State of Oregon Housing and Community Services Department Housing Development Revenue Bonds (Columbia Knoll Apartments Project) 2004 Series A	$6,628,167	68608AAS9
	Glen Ridge	$12,486,000 California Municipal Finance Authority Multifamily Housing Revenue Bonds (Glen Ridge Apartments) Series 2007	$11,890,000 (subject to future draws)	130483AS9
	Henson Ridge	$5,500,000 District of Columbia Housing Finance Agency Multifamily Housing Revenue Bonds (Henson Ridge UFAS Rentals Project) Series 2008	$5,500,000	25477PJB2
	Inwood Crossing	$20,000,000 City Of Wichita, Kansas Multifamily Housing Revenue Bonds Series 2007 (Inwood Crossings Apartments Project)	$17,525,000 (subject to future draws)	967276FY7
	Jefferson at Town Lake A-2	$5,670,000 Texas Student Housing Authority Student Housing Revenue Bonds (Jefferson Commons at Town Lake Project) Series 2002 A-2	$5,178,095	882793AQ5
	Lake Piedmont	$19,450,000 city of Indianapolis, Indiana Economic Development Multifamily Housing Revenue Bonds (Nantucket Cove Apartments Project) Series 1998	$19,118,000	626249AA4
	Mayfair Mansions	$42,000,000 District of Columbia Housing Finance Agency Multifamily Housing Revenue Bonds (Mayfair Mansions Apartments Project) Series 2007	$27,833,617(subject to future draws)	25477PJA4
	Meadows	The Health, Educational and Housing Facility Board of the City of Memphis, Tennessee Multi-Family Mortgage Revenue Refunding Bond (The Meadows Project), Series B 1995	$3,635,000	586170BW1

 

    	1-1

    	 

    
  

	Montclair 	The Industrial Development Authority of the City of Springfield, Missouri Multi-family Mortgage Revenue Refunding Bond (The Montclair Project) Series B 1995	$6,840,000	851003BJ1
	Newport Village	City of Thornton, Colorado Multi-Family Mortgage Revenue Refunding Bond (Newport Village Project), Series B 1995	$4,175,000	885283AM3
	Nicollet Ridge	City of Burnsville, Minnesota Multi-Family Mortgage Revenue Refunding Bond (Nicollet Ridge Project), Series B 1995	$12,415,000	122479EM6
	Oaks at Riverview	$1,550,000 Housing Finance Authority of Hillsborough County, Florida Multifamily Housing Revenue Bonds (Oaks at Riverview Project) 2004 Series A	$1,528,527	43232EBG3
	Park Villas	$5,550,000 City Of Waite Park, Minnesota Multifamily Housing Revenue Bonds (Park Villas Apartments Project) Series 2007	$5,550,000	930740AR6
	Spanish Fort	$12,500,000 Tax-Exempt Trust Certificates, Series 2008 Class A Certificates evidencing beneficial interests in $30,500,000 The Cooperative District of the City of Spanish Fort—Highway 98 Public Facilities	$12,500,000	87677GAA1
	Steeplechase	The Health, Educational Housing Facilities Board of the County of Knox, Tennessee Multi-Family Mortgage Revenue Refunding Bond (Steeplechase Falls Project), Series B 1995	$5,300,000	499520AK0
	The Landings	$16,670,000 Housing Authority Of The City Of Chula Vista Multifamily Housing Revenue Bonds (The Landings Apartments) Series 2007c	$16,670,000	17132AAM4
	Whispering Lake	Industrial  Development Authority of the City of Kansas City, Missouri Multi-Family Housing Revenue Refunding Bonds (Whispering Lake Project), Series B 1995	$8,500,000	485030CC2
	Willow Glen	$16,545,000 Housing Authority Of The City Of Sacramento Multifamily Housing Revenue Bonds (Willow Glen Apartments) 2007 Issue F	$16,545,000	78587NBQ8

 

Dated: February 1, 2009.

 

    	1-2

    	 

    
 

Schedule 2

Additional Bonds (Boot Bonds)

UR1

 

	Name	Issuer and Bonds	Principal
 Amount	CUSIP No.
	Brawley Elks	$2,025,000 California Statewide Communities Development Authority Multifamily Housing Revenue Bonds (Brawley Elks Senior Apartments) 2004 Series R-1	$2,005,733	13079PGQ0
	City Views at Rosa Burney Park A-2	$1,260,000 Urban Residential Finance Authority of the City of Atlanta, Georgia
 Multifamily Housing Revenue Bonds (City Views at Rosa Burney Apartments Project) Series 2002 A-2	$1,260,000	04785TGG8
	Cobblestone (2005)	$10,400,000 Housing Authority of Cobb County Multifamily Housing Revenue Bond (Cobblestone Apartments Project) Series 2005	$10,400,000	190901CM8
	Columbia Knoll	Senior Custody Receipt for payments of principal, premium, if any, and interest with respect to $24,500,000 State of Oreg  on Housing and Community Services Department Housing Development Revenue Bonds (Columbia Knoll Apartments Project) 2004 Series A	$17,700,000	68608AAR1
	Eden Park A-2	$850,000 Alachua County Housing Finance Authority Multifamily Housing Revenue Bonds (Eden Park at Ironwood Apartments Project) Series 2003 A-2	$850,000	01068LAF7
	Elmbrooke	$2,800,000 City of Minnetonka, Minnesota Multifamily Housing Revenue Refunding Bonds (Elmbrooke - Golden Valley Townhomes Project) Series 2000	$2,691,921	604217CP2
	Evergreen at Hulen Bend	$12,250,000 Tarrant County Housing Finance Corporation Multifamily Housing Revenue Refunding Bonds (Hulen Bend Seniors Apartments Project) Series 2005	$12,146,114	876394SV0
	Evergreen at Mesquite A-2	$2,200,000 Texas Department of Housing and Community Affairs Multifamily Housing Revenue Bonds (Evergreen at Mesquite Apartments) Series 2003 A-2	$2,200,000	88275BJR0
	Glenwood Farms	partial interest in $8,815,000 Harrisonburg Redevelopment and Housing Authority Multifamily Housing Revenue Bond (Glenwood Farms Apartments Project) Series 2003A	$1,950,000	415690MT0
	Lake Pleasant A-2	$1,890,000 The Industrial Development Authority of the County of Maricopa
 Multifamily Housing Revenue Bonds (Lake Pleasant Village Apartments Project) Series 2003 A-2	$1,890,000	566823SL5

 

    	2-1

    	 

    
 

	Liberty Park Townhomes A-2	$1,870,000 Camden County Improvement Authority Multifamily Housing Revenue Bonds (Liberty Park Townhomes Project) Series 2003 A-2	$1,870,000	13281RAB9
	Lincoln Corner G-2	$2,240,000 California Statewide Communities Development Authority Multifamily Housing Revenue Bonds (Lincoln Corner Apartments Project), GG-2 Series 2001	$2,240,000	13077VJ86
	Monroe	$12,025,000 Louisiana Public Facilities Authority Multifamily Housing Revenue Bonds (Monroe Affordable Housing, L.L.C. Project) Series 1998A and 1998B	$10,511,208	54640AY79
	Palisades Park	$9,750,000 Bexar County Housing Finance Corporation Multifamily Housing Revenue Bonds (Palisades Park Apartments Project) Series 1998	$7,475,352	088379NMO
	Rose Cove	$6,705,000 Utah Housing Finance Corporation Multifamilty Housing Revenue Refunding Bonds (Rose Cove Senior Apartments Project) Series 2004	$6,595,102	917434AZ5

 

UR2

 

	Name	Issuer and Bonds	Principal
 Amount	CUSIP No.
	Ashton Arbors	$8,600,000 Housing Authority of Cobb County Multifamily Housing Revenue Bond (Ashton Arbors Apartments Project) Series 2004	$8,600,000	190901CK2
	Ashton Grove	$9,400,000 Housing Authority of the County of Dekalb, Georgia Multifamily Housing Revenue bonds (Ashton Grove Apartments Project) Series 2005	$9,132,650	240471MK5
	Breckenridge	$12,300,000 Housing Authority of Clayton County, Georgia Multifamily Housing Revenue Bonds (Breckenridge Apartments Project) Series 2004	$12,300,000	184160KN8
	Cedar Park Ranch A-1	$9,200,000 Capital Area Housing Finance Corporation Multifamily Housing Revenue Bonds (Cedar Park Ranch Apartments Project) Series 2003 A-1	$9,070,348	139726BC6
	Cedar Park Ranch A-2	$1,150,000 Capital Area Housing Finance Corporation Multifamily Housing Revenue Bonds (Cedar Park Ranch Apartments Project) Series 2003 A-2	$1,133,793	139726BD4
	Desert Eagle A-2	$2,520,000 The Industrial Development Authority of the County of Maricopa Multifamily Housing Revenue Bonds (Desert Eagle Estates Project) Series 2003 A-2	$2,520,000	566823SS0
	Evergreen at Plano Parkway	$14,750,000 Texas Department of Housing and Community Affairs Multifamily Housing Revenue Bond (Evergreen at Plano Parkway) Series 2004	$14,615,764	88275BKX5

 

    	2-2

    	 

    
 

	Green Cay	$12,070,000 Housing Finance Authority of Palm Beach County, Florida Multifamily Housing Revenue Bonds (Green Cay Village Apartments Projects) Series 2006	$10,788,612	696513AA8
	Lakes at San Marcos	$16,800,000 Housing Finance Authority of Leon County, Florida Multifamily Housing Revenue Bonds (Lakes at San Marcos Apartments) Series 2005	$16,800,000	52643TAB6
	Leeward	$10,208,936 City of Los Angeles Multifamily Housing Revenue Bond (Leeward Preservation Apartment Project) Series 2005C	$9,788,982	544582VA4
	Lexington	$10,315,226 City of Los Angeles Multifamily Housing Revenue Bonds (Lexington Preservation Apartment Projects) Series 2005D	$9,880,863	544582VB2
	Mammoth Lakes (2004)	$5,500,000 Town of Mammoth Lakes Multifamily Housing Revenue bonds (Mammoth Lakes Family Apartments), Series 2004A	$2,495,311	56155PAA7
	Park Place at Loyola	$15,000,000 Texas Department of Housing and Community Affairs Multifamily Housing Revenue Bonds (Park Place at Loyola) Series 2007	$15,000,000	88275ABB5
	Penn Valley FF-2	$472,000 California Statewide Communities Development Authority Multifamily Housing Revenue Bonds (Penn Valley Apartments Project) Series 2001 FF-2	$472,000	13077VK27
	Planter's Retreat	$11,850,000 South Carolina State Housing Finance and Development Authority Multifamily Rental Housing Revenue Bonds (Planters Retreat Apartments Project) Series A	$10,880,299	83712EEP5
	Primrose at Pasadena	$12,180,000 The Southeast Texas Housing Finance Corporation Multifamily Housing Revenue Bonds (Primrose at Pasadena) Series 2004	$11,280,250	841514DE9
	Villas at Costa Cadiz	$8,200,000  San Antonio Housing Finance Corporation Multifamily Housing Revenue Bond (The Villas at Costa Cadiz Project) Series 2004	$8,100,035	796265FV3
	Walnut Grove	$4,900,000 California Statewide Communities Development Authority Multifamily Housing Revenue Bonds (Walnut Grove Apartments) Series 2003 R	$1,375,030	13077V3D2
	Wenmont	$6,210,000 South Carolina State Housing Finance and Development Authority Multifamily Rental Housing Revenue Bonds (Wenmont Apartments Project) Series 2005	$6,130,097	83712EEQ3
	Westchase Park	$14,400,000 Housing Authority of Fulton County, Georgia Multifamily Housing Revenue Bonds (Westchase Park Apartments Project) Series 2004	$14,270,747	360055EL7

 

    	2-3

    	 

    
 

	Woodland Village G-1	$6,528,000 Kansas Development Finance Authority Multifamily Housing Revenue Bond Series 2003 G-1 (Woodland Village Apartments Project)	$6,089,137	48542PDN5
	Woodland Village G-2	$1,632,000 Kansas Development Finance Authority Multifamily Housing Revenue Bond Series 2003 G-2 (Woodland Village Apartments Project)	$1,632,000	48542PDP0

 

UR3

 

	
         

        Name
	
         

        Issuer and Bonds
	Principal
 Amount	
         

        CUSIP No.

	R Street	$12,400,000 District Of Columbia Housing Finance Agency, Multifamily Housing Revenue Bonds (R Street Apartments Project) Series 2007	$12,300,000	254768QQ0

 

UR4

 

	
         

        Name
	
         

        Issuer and Bonds
	Principal
 Amount	
         

        CUSIP No.

	Villas at Shaver	$15,000,000 The Southeast Texas Housing Finance Corporation Multifamily Housing Revenue Bonds (Villas at Shaver) Series 2007	$15,000,000	841514DU3

 

Dated: February 1, 2009.

 

    	2-4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00201-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00201-of-00352.parquet"}]]